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ABSTRACT 
Background. The incidence rate of Chronic Kidney Disease (CKD) in 
Australia is rising rapidly. CKD leads to end stage kidney disease and the cost of 
treating the condition from 2009 to 2020 is estimated to account for $12 billion to the 
Australian health care system. At earlier stages of the disease, when the kidneys are 
not yet substantially damaged, proximal tubule epithelial cells (PTEC) of the kidney 
may play a very critical role in reducing extent of damage to kidneys and limit 
progression to CKD. PTEC are known to respond to and contribute to the 
pathological process in a range of kidney diseases. PTEC have been isolated and 
cultured along with purified immune cells and their interactions studied in simple 2-
dimensional (2D) allogeneic cell culture model and mouse models. More recently, 
using a 2D culture model it has been shown that PTEC are able to modulate the 
immune response in an autologous human system. However, 3D culture models 
would enable such immune modulatory processes to be studied within a more 
physiologically relevant setting. Therefore we aimed to recapitulate the 
PTEC/immune cell niche by developing a 3D hydrogel system in which PTEC and 
purified T cells could be cultured together and their interactions monitored using 
different techniques. 
 
Methods. The overall goal was to develop a 3D hydrogel system for the co-
culture of PTEC and purified populations of immune cells, which would enable the 
study of the immunomodulatory function of PTEC within a more representative in 
vivo environment. The first step was maintaining viability and in vivo morphology of 
purified immune cells and PTEC within a suitable hydrogel. To determine cell 
viability and morphology, the cells were stained within the gels with fluorescein 
diacetate (viable cells) and propidium iodide (dead cells). Images were taken with a 
confocal microscope. Immune cell functions were investigated by analysing the 
expression of classical antigen presenting and co-stimulatory molecules using flow 
cytometry. Protocols for gel dissolution were established to recover the immune cells 
and the PTEC from the hydrogel for analysis by flow cytometry. Part of the work 
also involved defining the chemokines secreted by PTEC under inflammatory 
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conditions, which are responsible for the migration of T cells in 2D cultures and 
through the extracellular matrix (ECM) in 3D gel systems. A human chemokine kit 
based on the cytokine bead array platform was used for this purpose.  To determine 
whether activated PTEC modulate responses of the autologous immune cells via their 
expression of activation/maturation Ags, up-regulation of cell surface markers were 
analysed with direct immunofluorescent staining with specific antibodies.  
Results. Data suggested that PTEC and T cells remain viable in type I collagen 
hydrogels for at least 7 days. Both PTEC and T cells were able to migrate and 
interact with each other when embedded in collagen gels. In collagen hydrogels T 
cells up-regulated activation markers CD25 and CD69, following mitogen 
stimulation, to similar levels as those in 2D cultures. Importantly, within these 3D 
gels, PTEC were able to more effectively down-modulate T cell responses than 
within 2D cultures. PTEC within these gels produced a range of chemokines 
including RANTES, IP-10, IL-8, MCP-1 and MIG. 
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Chapter 1: Introduction 
1.1. Background 
Chronic Kidney Disease (CKD) is a common chronic disease in Australia that 
is increasing at an alarming rate. CKD is usually asymptomatic and detected at later 
stages of the disease when substantial damage to the kidneys has already occurred. 
The disease often leads to a broad range of complications, such as hypertension, 
anaemia, malnutrition, bone disease, neuropathy, and decreased quality of life. End 
stage renal disease (ESRD) is reached when the glomerular filtration rate (GFR) falls 
below 15 mL/min per 1.72 m
2
 and patients need renal replacement therapy (RRT) or 
kidney transplant to survive. In Australia the incidence rate of treated ESRD is 
projected to increase by nearly 80 %—from 11 per 100,000 populations in 2009 to 
19 per 100,000 populations in 2020. This increase is anticipated to be mainly among 
patients aged 70 years and over (The Australian Institute of Health and Welfare, 
AIHW) [1]. As the incidence rate increases, the costs of treating end-stage kidney 
disease from 2009 to 2020 would account for $12 billion to the Australian health 
care system [2]. 
It is well accepted that regardless of the primary insult in kidneys, damage of 
the tubular epithelial cells and interstitium leads to renal dysfunction. During earlier 
stages of the disease, proximal tubule epithelial cells (PTEC) of the kidneys play an 
important role in recruiting inflammatory immune cells into the kidney interstitium. 
Previous published studies from the Conjoint Renal Medicine Laboratory at 
Queensland Institute of Medical Research (QIMR) Berghofer have shown that in 2-
dimensional (2D) cultures, primary human PTEC are able to modulate the functions 
of autologous
 
immune cells, possibly to reduce the degree of damage that can occur 
to kidney tubules during inflammation [3].  
The cellular microenvironment or extracellular matrix (ECM) is known to 
influence cell behaviour and function. It is evident from research that the ECM 
composition is able to control the fate of a cell. Cell matrix properties highly 
influence cell adhesion, migration and also cell signalling [4]. In kidneys, the cellular 
microenvironment is recognised to be correlated to renal function [5]. Therefore, we 
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hypothesized that a 3-dimensional (3D) in vitro model would more closely resemble 
the in vivo physiological conditions and provide the opportunity for the kidney cells 
and immune cells to exhibit their typical phenotype and functionality. 
The context of this thesis was to define a 3D environment for PTEC and 
immune cells as opposed to a conventional 2D culture. The investigation also 
included analysing the action of molecules involved in interactions between these 
two types of cells under a more physiological environment. The broader objective of 
developing a relevant 3D model of immune-renal cell interactions was to define 
molecules that could be targeted for use as therapeutics at earlier stages of CKD to 
prevent or ameliorate most of the complications of decreased renal function, as well 
as delay the progression to kidney failure. 
1.2. Purposes 
This thesis aimed to establish suitable 3D matrix systems for co-culture of 
PTEC and immune cells. Further, it aimed to recover cells and analyse changes in 
surface antigen expression by manipulating the physical and chemical properties of 
different 3D hydrogel systems. The results obtained from the 3D culture were 
compared with studies that were carried out using the traditional 2D culture system. 
Hence, this study sought to prove that in vivo -like organization of cells within gel 
constructs elicited more relevant and reliable interactions compared to 2D cell 
cultures. The use of multiple cell types in this model was critical in creating a more 
in vivo -like organization of the cells and observing appropriate cell physiological 
responses.  
 
1.3. Significance and Scope 
PTEC have previously been isolated and cultured along with purified immune 
cells and their interactions studied using traditional 2D culture. As most research 
involves 2D experimental systems, little is actually known about what occurs in a 3D 
environment. Therefore, this thesis seeks to fill this gap of knowledge by 
investigating the influence of a more physiologically relevant 3D model on the 
interaction of these two types of cells. In kidney research, the use of 3D models is 
not widespread and mainly limited to organ or organoid cultures. To overcome the 
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hurdles of these complex techniques, in this thesis a matrix made of a suitable 
hydrogel is defined to co-culture kidney and immune cells.  
This thesis was completed with the collaborative effort of the Cartilage 
Regeneration Laboratory (CRL) at IHBI, QUT, and the Conjoint Renal Medicine 
Laboratory at QIMR Berghofer. CRL has been working with 3D culture systems 
involving chondrocytes, bone marrow derived mesenchymal stem cells (MSCs), 
fibroblasts and a number of hydrogels [6, 7]. The Conjoint Renal Medicine 
Laboratory has previously studied autologous immune cell – renal cell interactions in 
2D cultures. Now, in a collaborative effort, this thesis defines a 3-D in vitro model to 
study immune cell – renal cell interactions. This model would enable us to gain novel 
insights into immune modulations of PTEC on the autologous immune cells in an 
environment more closely resembling that of native tissue.  
 
1.4. Hypotheses and Aims  
 
The overall goal of the project was to develop a 3D hydrogel system for the co-
culture of PTEC and purified populations of immune cells, to enable the study of the 
immunomodulatory function of PTEC within a more representative in vivo 
environment. To reach this goal, the project had the following specific aims:  
 
AIM 1: Define a suitable hydrogel capable of maintaining viability and 
function of purified T cells and autologous PTEC within the hydrogel; 
 
To construct a versatile model for the co-culture of primary PTEC and T cells, 
different types of hydrogels were studied. Biomaterials that closely resemble the 
native ECM and would allow the cells to exhibit a physiologically relevant 
phenotype were examined in this thesis. Suitability of gels were analysed by 
determining viability of the cells within the gels. Morphology and ability of the cells 
to interact within the defined 3D model were examined by live-cell imaging using a 
confocal microscope.  
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AIM 2: Develop techniques for recovery of the immune cells and the 
PTEC from the hydrogel for analysis. 
 
For the purposes of this study it was vitally important to not only identify a 
suitable gel matrix for both PTEC and immune cells but also to be able to dissociate 
these cells from the gel matrix and analyse their phenotypic and functional 
characteristics. The immune cells and PTEC were recovered from the gel system 
after being cultured for 6 days to determine their immunomodulatory functions. This 
recovery was achieved by dissolution of the gel constructs enzymatically or through 
the removal of calcium ions with chelating agents, such as EDTA or citric acid. A 
suitable chelator or enzyme and its concentration were optimised experimentally as 
these may affect the presentation of certain cell surface antigens (Ag).  
 
 
AIM 3: Monitor the immunomodulatory function of PTEC in the defined 
model system. 
 
Immune modulation by PTEC was determined by parameters such as 
expression of classical antigen presenting and co-stimulatory molecules. Interactions 
between PTEC and the immune cells within the 3D model were visualized by live 
cell microscopy. Effector T cell responses and cytokine secretion were analysed 
using flow cytometry and Cytometric Bead Array (CBA) respectively. The results 
obtained from 3D gel system were compared with 2D cell culture.  
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Chapter 2: Literature Review 
2.1. Kidney Anatomy and Physiology: 
2.1.1. Kidney structure and function 
Kidneys are bean-shaped organs located towards the back of the abdominal cavity 
which play numerous vital roles in the body including the excretion of wastes like urea and 
ammonium, maintaining acid-base balance, re-absorption of important substances (e.g. 
water, glucose, amino acids) and production of hormones including calcitriol, erythropoietin, 
and the enzyme renin. Kidneys also play a vital role in regulating blood pressure.  
 
 
The kidney is segmented into an inner section, called the medulla, and an outer section, 
called the cortex. The cortex contains approximately one million nephrons, which are the 
functional units of the kidney (Figure 2.1). Each nephron comprises of a network of 
capillary loops called the glomerulus, which is housed within the fluid filled Bowman‘s 
capsule and a complex ductal system. The Bowman‘s capsule extends into the duct system 
beginning with the proximal convoluted tubule, which is followed by the Loop of Henle and 
the distal convoluted tubule that finally drains into a collecting duct. Each region of the duct 
Figure 2.1 Cross section of a kidney (A) showing the nephron (B) Stained kidney tissue 
showing the glomerulus and proximal tubule epithelial cells (PTEC). (adapted from 
R.Wilkinson, Frontiers in Immunological Research presentation, Salzburg 2012). 
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system is distinct and differs in structure, function and morphology. The collecting ducts 
lead to the ureter, which drains urine into the urinary bladder. 
 The prime function of the proximal tubule is re-absorption of water, small proteins, 
amino acids, carbohydrates and electrolytes, whilst acid-base balance is partially regulated 
by both the proximal and distal tubule [8]. 
 The kidney is comprised of distinct cell types. The glomerulus and the Bowman‘s 
capsule consist of podocytes, mesangial cells and parietal cells. The glomerulus is lined by 
parietal cells and contains the mesangium that supports a network of blood capillaries. Blood 
is filtered through the glomerular filtration barrier. The barrier consists of endothelial cells, a 
basement membrane and podocytes. Molecules below 68kDa pass through the filter barrier 
to enter a duct system [9]. Juxtaglomerular cells and parietal cells together form the 
Bowman's capsule. Parietal cells protect the glomeruli and the juxtaglomerular cells release 
the hormone renin which functions to regulate blood pressure. The proximal and distal 
convoluted tubules are both lined with columnar epithelial cells that differ in appearance. 
Distal tubule cells are shorter, whereas PTEC are of greater columnar height and have brush 
borders which contain numerous megalin and cubilin receptors. Molecules that are not 
reabsorbed by the tubular system form the urine. The space between the tubules is called the 
interstitium and it is here where most of the intra-renal immune cells are found [8, 9]. 
 
2.1.2. Kidney resident immune cells 
A range of immune cell populations have been reported within a normal kidney. 
Macrophages lie adjacent to the basement membrane of PTEC in the outer medulla whereas 
dendritic cells (DC) are found in abundance in the tubulointerstitium. No DCs are found in 
the glomeruli .This strict localisation and strategic placement of DC is suggested to be 
optimal for antigen capture. Macrophages found in the medulla are believed to take part in 
homeostasis and repair mechanisms [9]. Monocytes are mostly present in the glomerular 
region of the kidneys [10, 11]. An infiltration of leukocytes from the surrounding blood 
capillaries occurs under perturbed disease states. 
 
2.1.3. The role of extracellular matrix 
Extracellular matrix (ECM) may be described as a three-dimensional framework of 
structural and functional proteins that not only provides physical support to the cells for their 
spatial organization but also regulates cell growth and proliferation by interacting with 
various growth factors. Research has shown that during kidney development and repair 
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processes, ECM molecules and their receptors play a crucial and dynamic role in providing 
an architectural scaffold for cell-cell and cell-matrix interactions [5, 12].  
ECM adhesion and assembly has a profound influence on cells. Besides providing a 
substrate for cell anchorage, it also guides the migration of cells during embryonic 
development and the wound repair process. ECM can play important roles in the 
differentiation of tissues. It is capable of transmitting environmental signals to cells, which 
affect various aspects of a cell‘s lifecycle like its proliferation, differentiation and death. 
Therefore, selection of an appropriate matrix for culturing cells is vital, as it can markedly 
affect the cellular responses [13]. 
The cellular microenvironment is recognised to be co-related to renal function. Renal 
disease progresses when ECM re-modelling occurs contributing to fibrotic scar tissue 
formation [14]. Excessive production of extracellular matrix components in conjunction with 
persistent kidney inflammation aggravates formation of fibrosis [15]. 
 
2.2.  Kidney Disease 
2.2.1. Chronic kidney disease (CKD) 
Chronic kidney disease is a gradual loss of function and structural integrity of renal 
cells over a period of time. In 2007 CKD accounted for approximately 10 % of all deaths in 
Australia. The mortality rate due to CKD is rising alarmingly [2]. CKD often has no 
symptoms and is usually detected in the later stages of the disease [16]. As the disease 
progresses, viable nephrons are lost and when a substantial portion of the kidney tissue gets 
destroyed, the glomerular filtration rate starts declining [17]. As low molecular mass 
compounds start accumulating in the blood, uraemia occurs. Irrespective of the nature of the 
initial insult, in the early phases of the disease there is an interstitial infiltration of 
inflammatory cells that leads to induction of tubular injury. In the end state of CKD, fibrotic 
tissue replaces the viable nephrons in the kidney [9], leading to end stage renal disease 
(ESRD), cardiovascular diseases (CVD) and premature death.  
Using conventional 2D cultures, studies performed in the Conjoint Renal Medicine 
Laboratory have successfully shown that PTEC of kidneys have immunomodulatory 
functions and can inhibit autologous immune responses under diseased inflammatory 
conditions. Activated primary PTEC under conditions mimicking inflammation can 
significantly decrease the proliferative responses of autologous T cells and also alter 
cytokine profiles [3]. This suggests that at earlier stages of the disease, when the kidneys are 
not yet substantially damaged, PTEC can play a very critical role in reducing the 
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inflammation and extent of damage to kidneys and limit progression to CKD [3]. 
Nonetheless, the 2D nature of these cell culture experiments does not match the native 3D 
environment of kidney. Therefore, this thesis aimed to investigate the immunomodulatory 
functions of activated primary human PTEC exerted on CD4+ T cells under autologous 
settings in a more in vivo like 3D environment. 
 
2.2.2. Mechanisms of kidney disease progression 
The original hypothesis with respect to mechanisms of kidney disease progression 
focused on damage to the glomerular compartment of the kidneys. Observations and analysis 
by Ridson in 1968 on renal biopsy specimens from patients with persistent glomerular 
nephritis led them to hypothesise that progression of CKD is caused by an insult to the 
tubular interstitium instead [18]. Later, Cameron et al. demonstrated that there was 
significant correlation between ammonia concentration in urine and the degree of tubular 
atrophy and interstitial fibrosis which supported Ridson‘s speculations [19]. In contrast, 
some studies again insisted that kidney disease was glomerulocentric as they were able to 
show that changes in glomerular pressure in murine models contributed to injuries to the 
glomeruli both structurally and functionally [e.g. 20]. However, further studies involving 
both human and rat models established that damage or lesions in the renal tubular 
interstitium were of major importance in determining progressive damage to kidneys [21, 
22]. Changes in the tubular interstitium of diabetic kidneys has also been shown to be related 
with a decrease in glomerular filtration rate and therefore kidney function [23]. Regardless of 
the disease aetiology it is now known that PTEC both respond and contribute to the disease 
process through a range of mechanisms.  
 
2.2.3. Immunomodulatory role of PTEC  
A pro-inflammatory environment is created within the kidney interstitium during the 
disease state. In response to injurious stimuli like high glucose, high protein levels and also 
diseases that cause inflammation in the kidneys,  PTEC secrete waves of chemokines such as 
transforming growth factor beta (TGF-β) , regulated upon activation normal T-cell expressed 
and secreted (RANTES) [24], monocyte chemotactic protein-1 (MCP-1) [25] and 
interleukin-8 (IL-8) [26]. These result in extravasations of lymphocytes, monocytes and 
macrophages to the renal interstitium from the surrounding blood capillaries, which then 
secrete a secondary wave of cytokines including tumour necrosis factor-α (TNF-α), gamma-
interferon (IFN-γ) and alpha-interferon (IFN-α) accentuating the inflammation (Figure 2.2). 
These inflammatory cytokines induce PTEC to up-regulate surface antigens, which include 
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major histocompatibility class I and II (MHC-I and II) [27], cluster of differentiation 40 
(CD40) [28], inducible T-cell co-stimulator ligand (ICOS-L) [29] and inhibitory 
programmed death ligand-1 (PD-L1) [30]. The up-regulation of these surface antigens allows 
PTEC to act as non professional antigen presenting cells (APCs) and modulate immune 
responses [31]. 
 
 
 
 
 
 
 
MHC class II are a family of molecules that are constitutively expressed on 
professional APC, but may also be induced on other cells by IFN-γ [32]. MHC class II 
Figure 2.2 Schematic showing how PTEC in a perturbed disease state recruit 
lymphocytes into kidney interstitium and modulate functions of these cells. 
(1) In the presence of injurious stimuli, the PTEC release (2) a range of chemokines e.g. MCP-1, IL-8 
etc. (3) which aid in the recruitment of leukocytes from the surrounding blood capillaries. (4)These 
lymphocytes then release cytokines which help in up-regulation of cell surface markers on the PTEC 
(e.g. PD-L1). Interactions between the lymphocytes and PTEC subsequently lead to a decrease in 
proliferation of the immune cells accompanied by a cytokine shift away from an inflammatory Th1 
effector profile to a Th2 type profile. (5) The PTEC also modulate dendritic cell function via complex 
interactions inducing weak Th1 responses (adapted from Healy et al. NHMRC grant application 
APP1046514, 2012). 
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molecules present antigen to CD4+ T cells initiating the first signal for T cell activation. T 
cells require a second signal which may be a co-stimulatory or co-inhibitory one and this 
second signal determines whether the T cell undergoes activation or becomes unresponsive. 
This second signal is generated when the second receptor at the interface between APC and 
T cell binds [33]. If stimulated by IFN-γ, PTEC are capable of expressing MHC class II 
molecules thereby demonstrating ability to modulate CD4+ T cell responses [34]. Our 
laboratory has also demonstrated that under inflammatory settings, PTEC up-regulate MHC 
Class II on their surface and modulate autologous human T cell responses [3].  
In vitro studies confirmed that PD-L1 is expressed at low levels on normal human 
PTEC but is up-regulated significantly in response to inflammatory cytokines, particularly 
IFN-γ [3, 35, 36]. The promoter region of PD-L1 contains several IFN-γ responsive elements 
and hence under inflammatory conditions in the presence of pro-inflammatory cytokine IFN-
γ, PD-L1 expression is up-regulated predominantly on non lymphoid tissues [37, 38]. PD-L1 
interacts with PD-1 (CD279) receptor found on T cells causing decreased T Cell Receptor 
(TCR) mediated proliferation and cytokine production [39].  
Thus it is likely that PTEC are capable of interacting with infiltrating immune cells in 
this perturbed inflammatory disease state. This has stimulated research using mouse models 
and allogeneic human systems [40, 41]. In an allogeneic model, transformed cell lines such 
as Human Kidney-2 (HK-2) cells, or primary PTEC from one donor are assayed against 
immune cells from a different donor. Results showed that PTEC are able to act as non-
professional APC by expressing MHC-II, CD40, PD-L1 and ICOS-L antigens on their 
surface. Additionally, the expression of PD-L1 on PTEC may have a tissue protective 
function against cytotoxic CD8+ T cell activity [42]. Further, renal expression of PD-L1 on 
human PTEC exerts an inhibitory effect on T cell responses [35, 43] and using αPD-L1 to 
block the ligand, it has been shown that PTEC were able to modulate T cell responses with 
respect to IL-2 secretion and CD69 expression [44].  
Our laboratory, using 2D cell culture systems, has previously demonstrated that PTEC 
can modulate immune responses within the autologous human system. Results showed that 
primary human PTEC activated by treating with IFN-γ, down-regulate autologous T cells 
and that this down regulation is only partially mediated by PDL-1. This modulation was not 
caused by a decrease in activation markers or an increase in T- regulatory cells (T regs) but by 
significant switching of cytokine profiles from T-helper type 1 (Th1) profile towards T 
helper type 2 (Th2) profile. Therefore, a significant decrease in IFN-γ, IL-2, TNF-α and 
increase in IL-4 production was seen [3].  
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In a more recently published paper, our laboratory has also demonstrated that in 2D cultures, 
human PTEC modulate autologous DC functions via complex interactions [45]. As the past 
observations have only ascribed a partial role to PD-L1 in down modulation of T cell 
responses, other immune-inhibitory molecules produced by PTEC were also examined in 
this thesis. One such molecule is the intracellular enzyme indoleamine 2, 3-dioxygenase 
(IDO). IDO is a tryptophan–catabolising enzyme and has immune suppressive effects on T 
cell functions [46]. 
Tryptophan is an essential amino acid that is required by T cells during proliferation. 
It is broken down to kynurenine during metabolism by the immunosuppressive enzyme IDO. 
IDO catalyses an initial step in the degradation of tryptophan along the kynurenine pathway 
thereby its presence limits the availability of tryptophan in the cellular microenvironment for 
T cell proliferation. The addition of 1 methyl-D-tryptophan (1MT) - an inhibitor of IDO in 
culture, allows tryptophan to be available to cells [47]. Earlier works on IDO suggested that 
cells that express IDO in an in vivo environment may act as APCs that can limit access to 
tryptophan during T cell activation [48] 
The immunomodulatory role of IDO was initially discovered by Munn et al. They 
demonstrated that during pregnancy, IDO played a role in restricting T cell mediated 
rejection of the allogeneic foetuses [49]. Their work triggered further studies on the 
immunomodulatory potential of IDO and numerous studies have since identified the 
expression of this enzyme in various tissues and cells that includes placenta [50], brain [51, 
52], liver [53], spleen [54], fibroblasts[55], endothelial cells [56], human bone marrow 
stromal cells [57] and many tumour cells [58, 59]. Myeloid cells such as DC and 
macrophages also produce IDO and are also able to inhibit T cell proliferation [60, 61]. This 
expression of IDO is regulated at the level of transcription. The gene for IDO has been 
cloned and shown to be differentially modulated by IFN-γ [62]. In response to IFN-γ and 
inflammatory stimuli, IDO expression is enhanced because the IDO promoter contains 
multiple promoter sequence elements such as interferon-stimulated response element (ISRE) 
and interferon-gamma activated sequence (GAS). Under inflammatory signalling, IDO 
induction occurs by phosphorylation of the latent signal transducer, activator of transcription 
1 α (Stat1α) at the IFN-γ-receptor (IFNGR). Stat1 then forms a dimer and translocates to the 
nucleus where it binds gamma-activated sequences (GAS) to activate gene expression of 
IDO [63].  
IDO expression has also been detected in mice kidney cells [64]. In mice, renal tubular 
epithelial cells express IDO when exposed to IFN-γ/TNF-α and promote apoptosis of tubular 
cells [65]. Some studies have demonstrated a correlation between IDO expression and CKD. 
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One study demonstrated that CKD patients having significantly elevated tryptophan 
metabolites in their serum compared to control groups [66].  
 
2.2.4. T cell and their interactions with PTEC in kidney  
2.2.4.1. T cell function 
T lymphocytes or T cells are important cellular components of the immune system 
that play a critical role in cell-mediated immunity. The development of T cells occurs in the 
thymus and therefore their name is derived from it [67].  
The primary function of T cells is to recognise non-self antigens or peptides bound to 
MHC molecules during antigen presentation and mount an appropriate immune response to 
eliminate the pathogen or infected cell. The recognition of a peptide-MHC complex occurs 
through a T cell antigen receptor (TCR) and acts as the first signal in the T cell activation 
process. Full T cell activation usually requires two further signalling events, (i) co-
stimulation and (ii) cytokine exposure, both of which are provided by the APC [68]. 
There are different types of T cells and each type has a distinct function. The different 
classes include T helper cells (Th cells), Cytotoxic T cells (TC cells, or CTLs), Regulatory T 
cells (Treg cells), Memory T cells and Natural Killer T cells (NKT). The two main classes of 
T cells are cytotoxic T cells and helper T cells. Cytotoxic or CD8+ T cells recognise peptides 
presented by MHC Class I molecules and kill virally infected cells and tumours and also 
participate in organ rejection process. 
Helper T cells, also known as CD4+ T cells because they express the CD4 glycoprotein on 
their surface, recognise peptide antigens (Ags) presented by MHC Class II molecules and 
help activate macrophages, B cells, and cytotoxic T cells. When activated, helper T cells 
secrete a variety of signal proteins called cytokines that aid the immune response. These cells 
can be differentiated into one of several subtypes, including Th1, Th2, Th17, Th9, Tregs and 
follicular B helper T cells (TFH), which secrete different cytokines to facilitate different types 
of immune responses. The differentiation is completely dependent upon the production of 
cytokines by APC. T cells are capable of migrating to distant sites and are believed to patrol 
almost all organs of the body, including the kidneys [69].  
 
2.2.4.2. T cell interactions with PTEC in kidney  
 Many studies have suggested that T cells might play an important role during 
progressive loss of renal function [61, 62]. A study has reported that T cells isolated from 
renal biopsies can be grown in vitro and are able to specifically lyse PTEC in a cytotoxicity 
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assay [63]. Interestingly, under conditions that mimic renal diseases, PTEC secrete a wave of 
chemokines that causes T cells to infiltrate the kidneys and accumulate at the site of 
inflammation. PTEC also up-regulate a range of surface antigens that enable them to both 
modulate immune responses and become targets of cytotoxic T cells. Early studies with 
murine models have suggested that CD4+ T cells infiltrate the kidney under inflammatory 
settings and activated PTEC can induce anergy in these infiltrating CD4+ T cells [70]. Using 
allogeneic models, it has been demonstrated that under proteinuric conditions, human PTEC 
are also able to interact with T cells that infiltrate the kidney [25]. It has also been shown that 
in kidney diseases like chronic proteinuric nephropathy and chronic glomerulonephritis, T 
cells and PTEC interactions are regulated by the production of differential chemokines and 
chemokine receptors. Infiltrating T cells may interact with PTEC either via secreting soluble 
factors or by direct cell-to-cell contact [71, 72].  
PD-1 is a transmembrane receptor of the immunoglobulin superfamily and has been 
shown to be expressed on thymocytes, mature T and B cells following activation and on 
myeloid cells [73]. In chronic infections or tumour invasion, the PD-L1/PD-1 pathway could 
be a key mechanism causing T cell exhaustion [39]. A study has previously demonstrated 
that in mouse, PTEC can act as APC to activate CD4+ T cells whereby PD-L1 is able to 
modulate the T cell response by modulating expression of CD69 and production of IL-2 [44]. 
This study was translated into human studies by a Dutch group using an anti-CD3/CD28 T 
cell activation model to show that PTEC modulated T cell responses via PD-L1 and ICOS-L 
[41]. Further studies were carried out to confirm that PD-L1 expressed on PTEC surface can 
suppress alloreactive human T cell responses [43]. 
Our laboratory, employing 2D cultures, has previously demonstrated that the 
inhibition of autologous T cell responses by activated PTEC is partially mediated by the PD-
L1/PD-1 pathway [3]. 
 
2.2.5. Chemokines and cytokines in kidney disease 
Chemokines are a family of small, chemotactic cytokines that can attract leukocytes to 
sites of tissue damage or inflammation [74]. The human chemokine family is comprised of 
more than 40 ligands (L) and 19 corresponding receptors. The four subfamilies are 
categorised based on the number and spacing of the first two conserved cysteine residues in 
the amino terminus - CCL, CXCL, CX3CL1 and XCL1 [75]. The majority of the 
chemokines can bind to multiple chemokine receptors of the same subgroup and are also 
capable of acting as antagonists for chemokine receptors of other groups [76]. Functionally, 
chemokines can be grouped into ‗inflammatory‘ chemokines that are inducible and 
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‗homeostatic‘ chemokines that are constitutively expressed by cells. Inflammatory 
chemokines attract effector leukocytes to sites of inflammation by causing extravasations 
through the blood vessels. The leukocytes then migrate along the chemokine gradient to 
reach the source. These inflammatory cells can release cytokines and growth factors to 
intensify the response and promote further injury. Growing evidence suggests that in kidney 
diseases, the influx of T cells and macrophages/monocytes into kidneys play a pivotal role in 
promoting interstitial fibrosis and the progression of CKD [77]. Research in renal diseases 
has mostly been focused on the inflammatory chemokines [78, 79]. 
Expression of chemokines in renal diseases has been reported to be correlated with the 
accumulation of effector leukocytes and renal damage. Animal models have been studied to 
characterise expression of chemokines in various kidney diseases and relevance has been 
established for expression of chemokines in human diseases by investigating human renal 
biopsies [77, 80]. Research on human PTEC has shown that in the presence of 
proinflammatory cytokines, PTEC produces significant amounts of RANTES/ CCL5 (by 
TNF-α and IFN-γ) [24], interferon gamma-induced protein 10 (IP-10)/ CXCL10 (by IFN-γ 
and TNF-α) [25], MCP-1/CCL2 (by TNF-α and IFN-γ) [71], IL-8/CXCL8 (by TNF-α) and 
fractalkine/CX3CL1 (by TNF-α) [81]. These chemokines can attract T cells expressing the 
receptors CCR5, CX3CR1 [82] and significantly a greater number of CD4+ T cells 
expressing CXCR3 [83]. All these findings were made using cell lines or 2D allogeneic cell 
culture models. The expression patterns of chemokines from human PTEC in an in vivo-like 
3D environment has not been yet reported.    
Using 2D cultures, our laboratory has also studied expression of cell surface 
molecules up-regulated by PTEC under the influence of different proinflammatory cytokines 
which included IFN-α, IFN-γ, TGF-β and TNF-α. Amongst these inflammatory cytokines, 
only IFN-γ seemed to have a major effect on the up-regulation of PD-L1 and MHC class II 
expression on PTEC. When IFN-γ and TGF-β were used in combination, an additive effect 
on the expression of PD-L1 on PTEC was observed [3]. 
This thesis focused on the expression patterns of cell surface molecules on PTEC 
under the influence of proinflammatory cytokines in 3D cultures, and also on the expression 
patterns of chemokines in 2D and 3D in vitro models under the influence of proinflammatory 
cytokines. 
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2.3. Tissue engineering and cell culture models 
2.3.1. 2D cell culture models 
Cell culture in two dimensions (monolayer) is commonly used in most laboratories, 
but does not closely approximate the in vivo environment of cells. 
In vivo, PTEC line the proximal tubule attached to a basement membrane on 
their basolateral side, where they can interact with immune cells within a 3D 
environment. Nonetheless, most of the experimental studies with PTEC commonly 
employ 2D culture systems to investigate individual cell types and interactions, 
which may have its limitations. At the very least, such cultures would see responding 
cells interacting with the apical side of the cultured PTEC instead of the basolateral 
side, as would occur in vivo. While it is relatively straightforward to use these cell 
culture models, 2D cultures and co-cultures do not always reflect the cellular 
responses seen in their in vivo analogues [82, 84, 85] and it seems logical to assume 
that the introduction of a 3D culture system would provide more relevant biological 
data and new insights. Study of cell migration using a 3D cell culture model and in 
vivo has revealed several differences when compared with cell migration in 2D, 
including cell morphology and mechanical and signalling control [86].  
 
2.3.2. 3D cell culture models 
Organ culture is among one of the oldest 3D culture techniques [87]. Although organ 
culture can resemble and provide information of in vivo events, but maintaining a direct 
organ culture is exceptionally difficult. The limiting factors include inability to precisely 
control different variables like oxygen diffusion to inner cells of the organ leading to high 
cell mortality. Organoid kidney 3D cultures have also been developed by encapsulating 
intact proximal tubule fragments in a hydrogel [88]. This model design retained cell-cell, 
cell-matrix, and tissue architecture and had been used for screening drug toxicity. But the 
major drawbacks of these cultures are the technical complexities, the meticulous and 
laborious preparations of the constructs, and insufficient oxygen diffusion into the deepest 
layers in the complex 3D model [88, 89].  
Hydrogels are the most prevalent and versatile 3D models for in vitro studies; these 
provide a well-hydrated matrix with options for tailoring matrix stiffness, cell adhesivity and 
degradability [6]. These are very promising when it comes to biomedical applications and 
are being used as drug and cell carriers, tissue engineering matrices, among others. Major 
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advantages of hydrogel systems are their similarities with natural tissues and their 
biocompatibility [90]. Hydrogels can also be tailored with specific biological features such 
as basement membrane components [91]. Additionally, these can be used to study specific 
cell interactions in a more controlled setting which is less complex than organ culture. 
Several types of hydrogels may be useful in the study of PTEC-immune cell interactions, 
ranging from simple and inert (such as alginate), to complex and highly cell active (such as 
Matrigel).  
Alginate hydrogel has structural similarity to extracellular matrices in tissues and has 
been extensively investigated and used for many biomedical applications [92]. Alginate is a 
naturally occurring polysaccharide typically extracted from brown algae (Phaeophyceae). It 
consists of a family of linear copolymers containing blocks of (1, 4)-linked β-D-mannuronate 
(M) and α -L- guluronate (G) residues. The blocks are composed of consecutive G residues 
consecutive M residues and alternating M and G residues. Alginate can undergo ionic cross-
linking where only G blocks are believed to take part in intermolecular cross-linking with 
divalent cations (e.g., Ca2+, Mg2+) to form hydrogels. This process is reversible through 
addition of chelating agents, such as ethylene diamine tetra-acetic acid (EDTA), thus 
allowing easy dissolution of the gels. Alginate is most frequently cross-linked ionically with 
calcium chloride (CaCl2) solution in a gelation process that relies on the diffusion of Ca
2+ 
ions into the alginate and often results in inhomogeneous gelation due to ion gradients within 
the gel. An alternative method for cross-linking alginate gels has been described by Kuo and 
Ma [93]. In this method calcium carbonate (CaCO3) is used as a source of calcium ions 
together with D-(+)-gluconic acid δ lactone (GDL) to initiate the process of gelation in the 
sodium alginate solution. This way a slower gelation rate is achieved by the slow release of 
calcium from the insoluble CaCO3, producing gels that are more uniform in structure and 
porosity. Uniform porosity ensures nutrients are able to diffuse through the gel to reach cells 
in the centre [94]. While alginate allows for straightforward encapsulation and recovery of 
cells, it lacks cell adhesion sites and allows no interaction between the gel and the cells [92]. 
Therefore, additional components may be required to model an interactive cell-extracellular 
matrix environment. 
Collagens, predominantly type I, are the main protein component of connective tissues 
in mammals, and thus are a good candidate for interactive components in a 3D culture 
system [95]. Collagens are high in glycine, representing every third position in the amino 
acid chain (gly-X-Y), and are responsible for the helical structure of collagen [96]. Acidic 
solutions of collagen can be adjusted for physiological pH at low temperatures (less than 10 
˚C ) and warmed to a higher temperature of 37 ˚C for about an hour to form a translucent gel 
[97]. These gels undergo dissolution if treated with collagenase enzymes. 3D gels of 
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collagen fibres have been used in the early 1980s by Schor et al. to study the migration and 
cell behaviour of different cell types in vitro [98-100]. Lymphocytes are highly motile cells 
constantly circulating in the blood, which under certain conditions undergo extravasations to 
migrate into the perivascular tissue space [101]. Collagen fibres are believed to be one of the 
main components of the tissue stroma through which lymphocytes migrate in vivo [102]. 
However, the complete understanding of the mechanism of T lymphocyte migration with 
respect to interactions with the extracellular matrix components is yet to be unveiled. Some 
groups of researchers have studied the roles of various components of the extracellular 
matrix using collagen as the 3D matrix to understand how these affect T cell invasion into 
tissues [103-105]. In the early 1990s, a study by the Sundqvist group showed that T cells 
migrate through 3D collagen substrata by adhesive mechanisms [106]. The Madin-Darby 
Canine Kidney (MDCK) cell line has also been cultured and studied in collagen gels [107]. 
A study with MDCK reported significant differences in cell behaviour when cultured in 2D 
and 3D [108]. Primary human PTEC isolated from urine were grown between two layers of 
collagen to successfully form three-dimensional structures [109]. Therefore, collagen 
comprising of natural proteins may be used in combination with alginate to provide cell 
adhesion sites for these cells in the gel. 
Gelatin-methacrylamide (GelMA) is a photocrosslinkable hydrogel that is derived 
from inexpensive gelatin. Gelatin is water soluble and made by denaturing collagen [110]. 
Gelatin has a wide use in tissue engineering applications, particularly for 3D cell culture 
models due to its biocompatibility, biodegradability, and ability to form hydrogels [111, 
112]. Unsaturated methacrylamide groups can be added to the amine containing side groups 
of gelatin under mild conditions to make a photo-polymerizable hydrogel that is stable at 37 
˚C [113]. Different cell types including immortalized human umbilical vein endothelial cells 
(HUVEC), NIH 3T3 fibroblasts [110] and aortic valvular interstitial cells (VIC) [114] have 
been encapsulated and cultured within GelMA gels. Our collaborating laboratory at IHBI, 
QUT has successfully shown that chondrocytes have a high cell viability within GelMA 
hydrogel and is a good candidate for cartilage tissue engineering [115]. This thesis intends to 
test the suitability of GelMA as a potential matrix for the co-culture of autologous PTEC and 
immune cells.  
While collagen-based hydrogels provide cell adhesion sites and other protein motifs, 
they are limited to a single protein, and therefore may not represent the native extracellular 
microenvironment very well. Thus, there is benefit in exploring models based on more 
complex protein/proteoglycan mixtures. Matrigel is an extract containing basement 
membrane proteins and growth factors derived from Engelbreth-Holm-Swarm (EHS) mouse 
sarcoma [116]. It forms a 3D gel around physiological temperatures and also promotes 
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differentiation and proliferation of many different cell types [91]. Matrigel is a complex mix 
of proteins and abundant in basement membrane proteins like laminins, type IV collagen, 
perlecan and nidogen/entactin. It also contains growth factors, such as transforming growth 
factor β (TGF-β), fibroblast growth factor (FGF), epidermal growth factor (EGF), platelet 
derived growth factor (PDGF) and insulin-like growth factor (IGF) [91, 117].  
Matrigel could be a good candidate for serving as a 3D matrix for PTEC as research 
has shown that renal PTEC have a high cell attachment and proliferation on Matrigel [118]. 
To keep the influence of growth factors as low as possible growth factor reduced (GFR) 
Matrigel will be used. However, the handling of Matrigel hydrogels is challenging as these 
gels are very soft and easily disintegrate during culture. Therefore, combining Matrigel with 
alginate is a promising approach, as the addition of alginate could increase the stability and 
stiffness of Matrigel hydrogels while maintaining their biological activity. 
Combinations of gels with varying matrix properties have already been used for the 
co-culture of different types of cells [119]. However, recovering these cells from the matrix 
to further dissect the mechanisms of interactions between them is not very common.  
Attempts to engineer 3D in vitro models for normal and diseased kidney have been 
made by co-culturing immortalized mouse embryonic kidney (MEK) epithelial cells with 
mouse fibroblasts within silk-based porous scaffolds with collagen-matrigel content [120]. 
Most recently to build a human in vitro model that mimics the renal proximal tubule, small 
intestinal submucosa (SIS) was used as a scaffold to grow cadaveric human kidney-derived 
cells (hKDc) [121]. 
 
2.4. Hypotheses 
In view of the current literature, it was proposed that there were no evidences of how 
3D in vivo like environment influenced co-culture of primary human PTEC and autologous 
immune cells.  
Therefore the aim was to fill this gap of knowledge by investigating the influence of a 
more physiologically relevant 3D model on the interaction of these two types of cells. We 
proposed to define a 3D in vitro model that could sustain both the kidney PTEC and immune 
cells. We hypothesized that studying these two types of cells within a 3D environment would 
provide new and interesting insights into their interactions. The results obtained from the 3D 
culture were compared with studies carried out using the conventional 2D culture system. 
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2.5. Aims 
1. Define a suitable hydrogel capable of maintaining viability and function of 
purified T cells and autologous PTEC within the hydrogel.  
2. Develop techniques for recovery of the immune cells and the PTEC 
from the hydrogel for analysis. 
3. Monitor the immunomodulatory function of PTEC in the defined model 
system. 
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Chapter 3: Materials and Methods 
This chapter contains an overview of the materials and methods used throughout the 
thesis. 
 
3.1. Materials 
Table 1: Materials used 
 
 
 
REAGENTS 
FINAL 
CONCENTRATION 
SUPPLIER 
DMEM F12  
Invitrogen; 
Catalogue No.: 11330057 
Fungizone  
Invitrogen ;  
Catalogue No.: 15290018 
Sterile Scalpel  
Swann-Morten Disposable 
Sterile Scalpels Ref No. 0508 
100 µm Nylon Cell 
Strainer 
 
BD Falcon; 
Catalogue No.: 352360 
40 µm Nylon Cell 
Strainer 
 
BD Falcon; 
Catalogue No.: 352340 
HEPES Buffer  
Invitrogen; 
Catalogue No.: 15630-08 
L-Glutamine and 
Pyridoxine 
Hydrochloride 
 Invitrogen 
Epidermal Growth 
Factor 
10 ng/mL 
Sigma-Aldrich;  
Catalogue No.: E9644 
Hydrocortisone 36 ng/mL 
Sigma-Aldrich;  
Catalogue No.: H0396 
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Tri-Iodothyronine 4 pg/mL 
Sigma-Aldrich 
Catalogue No.: T5516 
 
Penicillin-Streptomycin 
Penicillin 100 U/mL 
Streptomycin 100µg/mL 
Invitrogen   
Catalogue No.:15140-
122 
ITS (Insulin –Transferrin-
Selenium) 
 
Insulin 10µg/mL 
Transferrin 5μg/mL 
Selenium 5ng/mL 
Sigma-Aldrich;  
Catalogue No.: I1884-
1VL 
TrypLE™ Express  
Invitrogen; 
Catalogue No.: 12604-
021 
TrypLE Inhibitor  
Invitrogen; 
Catalogue No.: R007-
100 
IFN-γ 100 ng/mL 
R&D Systems; 
Catalogue No.: 285-IF-
100 
IL-4 1000 U/mL 
Miltenyi Biotech 
Catalogue No.: 130-
093-922 
Ficoll  
GE Health; 
Catalogue No.: 17-
1440-03 
Sterile Syringe  
Terumo syringes Luer 
lock 50mL Catalogue 
no.1260603 
Sterile Cannula  
Uno medical 
Catalogue No. 
500.11.012 
Haemocytometer  Boeco 
Trypan Blue  Sigma 
Olympus Cx40  Olympus Corporation 
3[H]-Thymidine 5 µCi/mL Perkin Elmer 
90 X 120 Mm Glass Fibre Filter 
Mat 
 Perkin Elmer 
90 X 120 Mm Filter Mat Sample 
Bags 
 Perkin Elmer 
Human CD4 Micro-Beads  
Miltenyi Biotech; 
Cat No.: 130-045-101 
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Anti-PD-L1 10 µg/mL 
Bio Legend 
Catalogue No.: 329702 
Phytohaemagglutinin 
(PHA-P) 10 µg/mL 
Sigma-Aldrich; 
Catalogue No.: L8754-5MG 
Anti Human CD3 
0.5 µg/mL 
Abcam  
Catalogue No: AB8090 
Anti Human CD28 
0.1 µg/mL 
Abcam  
Catalogue No.: AB85986 
Collagenase P 
1 mg/mL 
Roche 
Catalogue No.: 11 213 857 
001 
Collagenase From 
Clostridium 
Histolyticum 
1 mg/mL 
Sigma-Aldrich 
Catalogue No.: C6885-1g 
DNase I 
20µg/mL 
Roche 
Catalogue No.: 11284932001 
Carboxyfluorescein 
Diacetate Succinimidyl 
Ester (CFSE) 
0.5µm BioLegend 
Labtek 11 Chambered 
Cover Glass Non 
Removable Upper 
Chamber 
 
Thermo Fisher Scientific 
Catalogue No.: NUN155409 
0.2µ filter 
 
Minisart Sartorius 
Catalogue No.:16534k 
Bovine Serum 
Albumin (BSA)  
Sigma-Aldrich 
Catalogue No. :A7906-100G 
DAPI  
5 µg/mL 
Sigma-Aldrich 
Catalogue No. :D9542-5MG 
Rhodamine Phalloidin  
0.8U/mL 
Invitrogen 
Catalogue No. : R415 
16% 
Paraformaldehyde 
(PFA) methanol free 
 
Electron Microscopy Sciences 
Catalogue No. :15710 
Collagen Solution 
 
Sigma-Aldrich 
Catalogue No. :C4243 
Gelatin 
methacrylamide 
(GelMA) 
 
Obtained from CRL, IHBI, 
QUT. 
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Fluorescein diacetate 
(FDA) 10 μg/mL 
Invitrogen 
Catalogue No. : F1303 
Propidium Iodide (PI) 
5 μg/mL 
Invitrogen 
Catalogue No. : P21493 
Monoclonal rabbit 
IgG anti-human E-
Cadherin 
1 in 150 dilution 
Cell Signalling Technology 
Catalogue No. : 3195 clone 
24E10 
Alexa Fluor® 647 –
labelled lectin PNA 
from Arachis 
hypogaea (peanut) 
20µg/mL 
Invitrogen 
 
Catalogue No. : R415 
Mouse anti-human 
collagen type IV 
(IgG1κ) 
3.5µg/mL 
DSHB, USA 
Clone M3F7 
Alexa Fluor® 488 –
labelled Affinipure 
donkey anti-mouse 
IgG (H+L) 
4.7 μg/mL 
Jackson ImmunoResearch 
Catalogue No. :115-585-152 
Alexa Fluor® 594 –
labelled Affinipure 
donkey anti-rabbit 
IgG (H+L) 
4.7 μg/mL 
Jackson ImmunoResearch 
Catalogue No. : 711-585-152 
Alginate powder 
 
Pronova UP LVG, 
Novomatrix 
Catalogue No. :4200006 
MatrigelTM matrix 
 
BD Biosciences Catalogue 
No. : 356231 
Irgacure 2959 ( 2-
hydroxy-1-[4-(2-
hydroxyethoxy)pheny
l]-2-methyl-1-
propanone) 
2.5 mg/mL 
BASF, Ludwigshafen, 
Germany 
 
24w Plate, Ps, TC 
Treated, F-Bottom, 
W/ Lid 
 
Greiner Bio-One 
Catalogue No.: 662160 
Dulbecco‘s Phosphate 
Buffered Saline ,Ca 
And Mg Free (PBS) 
 
Invitrogen 
Catalogue No. :14190-144 
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  BD Cytometric 
Bead Array 
(CBA) Human 
Chemokine Kit  
 
BD Biosciences 
Catalogue No. : 552990 
 
BD Cytometric 
Bead Array 
(CBA) Human 
Th1/Th2 Cytokine 
Kit II 
 
BD Biosciences 
Catalogue No. : 551809 
BD Cytometric 
Bead Array 
(CBA) Human 
Inflammatory 
Cytokines Kit 
 
BD Biosciences 
Catalogue No. : 551811 
D-(+)-Gluconic 
acid δ lactone 
(GDL) 
60mM 
Sigma-Aldrich 
Catalogue No. G4750-100G 
 
TNF-α 20ng/mL 
R&D Systems (from 
Bioscientific) 
Catalogue No.  210-TA-020 
1-Methyl-DL-
Tryptophan 
(1MT) 
 
1500µM/mL 
Sigma-Aldrich 
Catalogue No. 860646 
Transforming 
growth factor -1 
(TGF-β 1) 
20 ng/mL 
R & D systems. 
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3.2. Cell culture 
3.2.1. Origin of PTEC 
Following ethics approval and informed consent, kidney tissue was obtained 
from the healthy portion of tumour nephrectomies. Cortex tissue was dissected from 
macroscopically/microscopically normal portions of the kidney and processed for 
PTEC purification within 1 h.  
PTEC were purified following the method of Glynne and Evans [122] and 
cultured in defined medium (DM) comprised of 1:1 mixture of Dulbecco‘s modified 
Eagle‘s medium (DMEM) and Ham‘s F12 containing 15 mM HEPES buffer, L-
glutamine and pyridoxine hydrochloride. The medium was supplemented with 
epidermal growth factor (10 ng/mL), insulin (10 µg/mL), transferrin (5 µg/mL), 
selenium (5 ng/mL), hydrocortisone (36 ng/mL), tri-iodothyronine (4 pg/mL), 
penicillin (100 U/mL), streptomycin (100 µg/mL). Briefly, the cortex of the kidney 
was detached from its outer capsule, washed thoroughly using DMEM media 
supplemented with fungizone and cut into small pieces of an approximate size of 1 
mm
2
 using a sterile scalpel (Labtech). The tissue was then digested using collagenase 
(Sigma C6885, 1 mg/mL) for 1 hr at 37 °C with vortexing every 10 min. The 
resulting cell suspension was passed through a 100 μm nylon cell strainer (BD 
falcon) followed by a 40 μm nylon cell strainer (BD falcon). The flow-through was 
centrifuged at 1000 rpm for 5 min. The supernatant was discarded and the pellet was 
resuspended in DM. 
Cell stocks were frozen at passage 1 (P1), and all PTEC were used in final 
experiments between P2 and P3. PTEC were characterized on the basis of (i) strong 
staining for cytokeratin-18, (ii) strong staining for alkaline phosphatase activity using 
the naphtal AS-MX method and (iii) characteristic cobblestone morphology. 
 
3.2.2. Maintenance of PTEC 
PTEC were cultured in DM at 37 °C with 5 % CO2 under constant humidity. 
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3.2.3. Passage of PTEC 
 Where required, cells were passaged when they were 80 % confluent to 
maintain optimum viability. The supernatant was removed and the cells washed 
twice in Mg
2+
 and Ca
2+
-free phosphate-buffered saline (PBS). TrypLE™ Express 
(1x) was added to the cell monolayer to detach the cells from the culture flask. 
Following incubation at 37 °C for 5 minutes, trypsinization of cells was stopped by 
adding an equal volume of Defined Trypsin inhibitor (Invitrogen). Cells were 
washed twice in DM and re-suspended at a 1 in 10 dilution for passaging. 
 
3.2.4. Cryopreservation of PTEC 
For PTEC cryopreservation, following centrifugation the cells were 
resuspended in a final concentration of 1x10
6
-2x10
6
 cells/mL in serum-free 
cryopreservation media constituting of 90 % DM media and 10 % dimethyl sulfoxide 
(DMSO) (Sigma-Aldrich). 1 mL aliquots of cell suspension were then distributed 
into thermo scientific cryotube vials and placed in a -80 °C freezer in Mr. Frosty 
Cryo freezing containers (Nalgene). After 24-48 hours, cells were transferred to 
liquid nitrogen for long-term storage. 
 
3.2.5. Revival of cryo-preserved PTEC 
To thaw the PTEC, cells were quickly removed from liquid nitrogen and 
warmed to room temperature by transferring to a 37 °C water bath. To prevent 
osmotic lysis, culture media was added to the cell suspension very slowly drop-wise. 
The resulting cell suspension was centrifuged at 190 g for 5 minutes and the cell 
pellet re-suspended in DM before transferring to a cell culture flask. PTEC were 
maintained as described in section 3.2.2. 
 
3.2.6. Activation of PTEC 
 
P2 PTEC were cultured in DM until 70-80 % confluent and exposed to IFN-γ 
(100 ng/mL), for 36 hrs. Cells were gently detached with TrypLE™ Express (1x), 
neutralized immediately with Trypsin inhibitor (Invitrogen), washed once in DM and 
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re-suspended in DM for culture experiments or phosphate-buffered saline (PBS) 
containing 0.02 % sodium azide and 0.5 % bovine serum albumin (BSA) (FACS 
buffer) for cell staining . 
 
3.2.7. Irradiation of PTEC 
Where required, PTEC were exposed to γ-radiation at 30 Gy in a Gamma-cell 
irradiator to prevent further cell division. 
 
3.2.8. Origin of Blood cells 
Blood was obtained from the same donors 3 to 6 months post-nephrectomy. 
PBMC were isolated by Ficoll-density gradient separation (refer section 3.2.9). CD4
+
 
T cells were purified from PBMC using Miltenyi Microbeads (Sydney, Australia) 
following the manufacturer‘s instructions (refer section 3.2.12).  
 
3.2.9. Peripheral blood mononuclear cells (PBMC) enrichment from 
whole blood 
For PBMC isolation by Ficoll-density gradient separation, 20mL blood was 
diluted 1:2 with sterile room-temperature PBS in a 50 ml Falcon tube and underlain 
with 10 mL Ficoll-Paque™ Plus (GE Healthcare) using a sterile syringe fitted with a 
sterile cannula. Samples were centrifuged at room-temperature at 373 g for 20 min 
with brakes turned off. PBMC were then carefully collected from the Ficoll interface 
with a sterile plastic transfer pipette, washed 3 times in ice cold PBS, and 
resuspended in either complete medium (CM) consisting of Roswell Park Memorial 
Institute medium 1640 (RPMI-1640) supplemented with 2 mM glutamine, 10 mM 
HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), 1 mM pyruvate, 0.1 
mM nonessential amino acids, 50 µM 2-mercapto ethanol, penicillin (100 U/mL), 
streptomycin (100 µg/mL) and 10 % heat-inactivated human AB serum for use in 
subsequent experiments or put into freezer medium (50 % Fetal Calf Serum (FCS) 40 
% RPMI-1640 medium,10 % dimethylsulfoxide (DMSO)) for cryopreservation (refer 
section 3.2.10). 
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3.2.10. Cryopreservation of PBMC 
Appropriate volumes of cryopreservation media comprising of 10 % DMSO 
(Sigma-Aldrich), 50 % heat-inactivated foetal calf serum (FCS) and 40 % RPMI 
media were slowly added to PBMC for a final concentration of 25x10
6
 cells/mL. 1 
mL aliquots of cell suspension were then distributed into thermo scientific cryotube 
vials and placed in -80°C freezer in Mr. Frosty Cryo freezing containers. After 24-48 
hours, cells were transferred to liquid nitrogen for long-term storage. 
 
3.2.11. Revival of cryo-preserved PBMC 
Upon removal from liquid nitrogen, PBMC were transferred to a 37 °C water 
bath as fast as possible until completely thawed. Culture media was added to the cell 
suspension drop-wise very slowly in order to prevent osmotic lysis of the cells. The 
cell suspension was washed twice (centrifuged at 373 g for 5 minutes) and the cell 
pellet re-suspended in CM for use in experiments. 
3.2.12. CD4+ T cell isolations from PBMC 
Following manufacturer‘s instructions, CD4+ T cells were purified from PBMC 
using Miltenyi Microbeads (Sydney, Australia). Briefly, PBMC isolated from donor 
blood were counted and washed at 373 g for 5 minutes. Supernatant was completely 
removed and cells resuspended in 80 µL of MACS buffer comprising of 0.5 % BSA, 
2 mM EDTA and Ca
2+
/Mg
2+
-free PBS per 10
7 
total PBMC. 20 µL of CD4 
microbeads (Miltenyi Biotech) were added per 10
7 
cells. The cell suspension was 
incubated in the fridge for 15 minutes, with minor mixing every 5 minutes, followed 
by a wash at 373 g for 5 minutes. Supernatant was removed completely and cells re-
suspended in 500 µL of MACS buffer/10
8 
cells. The suspension was passed through 
a column (LS column Miltenyi Biotech) placed in a magnetic field. Unlabelled cells 
that passed through the column were collected  as‖flow-through‖. Following 3 x 500 
µL washes, the column was removed from the magnetic field and a plunger was used 
to flush magnetically labelled CD4
+
 T cells out of the column. Based upon CD4 
staining, the purity of CD4
+
 T cells was generally greater than 96 %. 
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3.2.13. Cell counting 
A cell sample was diluted 1:2 with trypan blue (Sigma) and mixed thoroughly. 
10 μL of cell suspension was then loaded into the haemocytometer counting chamber 
(Boeco, Germany). Live cells, marked by trypan blue exclusion, were counted from 
one or more corner squares of the haemocytometer counting area using an Olympus 
CX40 phase contrast microscope (Olympus Corporation). Cell concentration was 
calculated using the formula:  
 
Cell concentration/mL = (Average number of live cells counted from one or more 
corner squares of the haemocytometer) X (dilution factor) X 10
4
 
 
For a viability count in a given sample, dead cells, stained blue with trypan 
blue, were also counted to obtain the total number of cells and percentage viability 
was calculated as: 
 
Viability percentage = (Average number of live cells counted from one or more 
corner squares of the haemocytometer / Average number of all cells counted from 
one or more corner squares of the haemocytometer) X 100 
 
 
3.3. Fabrication of hydrogels 
To define hydrogel constructs for optimal interaction and viability of immune 
cells and PTEC in co-cultures, various combinations of different gels were studied. 
 
3.3.1. Cell encapsulation and cell differentiation in different gel 
mixtures  
3.3.1.1. Alginate gel preparation 
A stock solution of 2 % (w/v) Alginate was prepared by dissolving alginate 
powder (Pronova UP LVG, Novomatrix) in normal saline (150 mM) and the mixture 
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filter sterilised. To achieve controlled gelation, sterile alginate solution was mixed 
with sonicated Calcium Carbonate (CaCO3, 30 mM) suspension and kept at a 
temperature of 2-4 ˚C. Alginate solution had a final concentration of 1 % in the 
resulting gel mixture. CD4
+
 T cells (1x10
6 
cells/ml) and PTEC (5x10
5 
cells/ml) were 
washed at 1400 rpm for 5 mins and re-suspended in the alginate-CaCO3 suspension. 
Freshly prepared D-(+)-gluconic acid δ lactone (GDL, 60 mM) was added to 
alginate-CaCO3 mix containing cells. The mixture was gently pipetted up and down 
to obtain a homogenous solution. The resulting mixture was put in glass slide 
chambers (Thermo- Fisher Scientific) in 50 µl droplets and incubated at 37˚C and 5 
% CO2 for approximately 30 mins until gel formation occurred. CM was added to the 
gels. The gels were incubated and viability of cells was checked at different time 
points (refer section 3.9). 
 
3.3.1.2. Matrigel gel preparation 
CD4
+
 T cells (1x10
6 
cells/ml) and PTEC (5x10
5 
cells/ml) were washed and 
mixed gently with MatrigelTM matrix (0.9 % w/v, growth factor-reduced, phenol red 
free; BD Bioscience, Bedford, MA, USA). Cold sterile tips were used to add the 
Matrigel - cells mix into glass slide chambers (Thermo- Fisher Scientific) and 
incubated at 37 ˚C 5 % CO2 for 25-30 mins until gels formed.  
 
3.3.1.3. Alginate – Collagen gel preparation 
Collagen type I solution (Sigma-Aldrich) was first neutralized and pH adjusted 
according to manufacturer‘s instructions. Briefly, 8 parts of chilled collagen solution 
was mixed with 1 part of sterile 10X PBS. The pH was adjusted to 7.2-7.5 by adding 
sterile 0.1 M NaOH. To prevent gelation of collagen, the temperature was maintained 
at 2-8 ˚C.  
 Alginate (Pronova UP LVG, Novomatrix) solution was prepared as described 
in section 3.3.1.1. To 50 µL of stock alginate solution, 5 µL of CaCO3 and 40 µL of 
neutralized collagen solution were added. This suspension was mixed with cells. The 
final concentration of CD4
+
 T cells was 1x10
6 
cells/ml and PTEC was 5x10
5 
cells/ml 
in the gel. Finally, 5 µL of freshly prepared GDL was added to this mixture before it 
was pipetted into glass slide chambers (Thermo- Fisher Scientific) in 50 µL droplets 
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and incubated at 37 ˚C in a humidified atmosphere of 5 % CO2 for 30 mins until gels 
formed. CM was added to the gels for culture. Cells encapsulated within gels were 
analysed at different time points for cell viability (refer section 3.9). 
 
3.3.1.4. Alginate- Matrigel construct preparation 
A stock solution of alginate (Pronova UP LVG, Novomatrix) was prepared 
(refer section 3.3.1.1) and combined with Matrigel
TM
 matrix (0.9 % w/v, growth 
factor-reduced, phenol red free; BD Bioscience, Bedford, MA, USA). Briefly, 50 µL 
of 2 % alginate was mixed with 5 µL of CaCO3 (300 mM) and 40 µL of Matrigel. To 
this mix, cells were resuspended keeping the final concentration of CD4
+
 T cells 
1x10
6 
cells/ml and PTEC 5x10
5
cells/ml. The mixture was gently pipetted up and 
down to obtain a homogenous suspension before being put into glass slide chambers 
(Thermo- Fisher Scientific) and incubated at 37 ˚C & 5 % CO2. After 25-30 mins 
when the gels had formed, CM was added to the gels. Cell viability was analysed as 
described in section 3.9. 
 
3.3.2. GelMA cell culture model  
GelMA was generously supplied by the Cartilage Regeneration Laboratory 
(CRL) at IHBI, QUT. Briefly, Type A gelatin (Molecular weight [MW] ~ 90 kDa) 
purchased from Sigma-Aldrich was modified to include photocrosslinkable groups 
by reaction with methacrylic anhydride (MAAh) (Sigma-Aldrich). Gelatin was 
dissolved in PBS (Invitrogen, Carlsbad, CA) at 100 mg/mL and reacted with 0.6 g 
MAAh per gram gelatin for 1 h at 50 ˚C under continuous stirring. Insoluble MAAh 
was removed by centrifugation, and remaining MAAh was removed by dialysis 
against distilled water (12 kDa MWCO cellulose dialysis membrane, Sigma-
Aldrich). Functionalized polymers were lyophilized. 
A GelMA stock solution of 6.25 % (w/v) from the lyophilized GelMA 
(obtained from CRL, IHBI) was prepared a day in advance. First, preheated sterile 
PBS (70 ˚C) was added to photoinitiator (PI): 2-hydroxy-1-[4-(2-hydroxyethoxy) 
phenyl]-2-methyl-1-propanone (Irgacure 2959) to make a 2.5 mg/mL solution. The 
mix was then placed in 70 ˚C water bath and shaken until completely dissolved. 
Following filter sterilisation through a 0.2 µm filter (Minisart Sartorius), the PI was 
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diluted 4 times in sterile PBS. Appropriate amount of GelMA to make 6.25 % was 
measured and added to the diluted PI supplemented PBS. The tube was wrapped in 
foil and left overnight at 4 ˚C.  
The next day soaked GelMA was warmed in a water bath (37 ˚C) until it 
completely dissolved. CD4
+
 T cells (final concentration in gels 1x10
6 
cells/ml) were 
washed at 373 g for 5 minutes and resuspended in sterile PBS in 1/5 of the final 
volume of GelMA solution. Prepared PI supplemented GelMA solution was added to 
it and mixed well. Final concentration of GelMA was 5 % (v/v of stock solution) and 
PI was 0.5 mg/mL. The GelMA–cell mix was pipetted into Teflon moulds (Figure 
3.1) slightly over filling the grooves to avoid air bubbles. Sterile microscopic glass 
slides were placed to cover the moulds and placed in the centre of a photo-cross 
linker (wavelength = 365 nm). After 5 minutes the gels were removed from the 
mould and cut into 10 x 5 mm gels using a cutting guide. 
 
The gels were placed in a 24 well flat bottomed plate (Greiner Bio-one) and 1 
mL of CM was added to the gels in each well. Incubation was continued for 1 hour at 
37 ˚C in a humidified atmosphere of 5 % CO2. After 1 hour the media was taken out 
and 5 µL of PTEC (concentration = 2X10
6 
cells/mL) was added on top of the gels. 
This was incubated for 3 hours under the same conditions. At the end of 3 hours 
when the PTEC had attached to the gel surface, warm CM was added and the gels 
incubated at 37 ˚C and 5 % CO2. At different time points the gels were taken out of 
the cultures to monitor viability and stain for various cell surface and intracellular 
markers.  
Figure 3.1 Teflon Mould for GelMA gels. 
 Chapter 3: Materials and Methods 47 
3.3.3. Type I Collagen gel culture model. 
Collagen type I solution (Sigma-Aldrich) was first neutralized and pH adjusted 
according to manufacturer‘s instructions as described in section 3.3.1.3. Chilled 
neutral collagen was transferred to 96 well flat bottomed plates (Nalgen Nunc 
International) at 50 µL/well to coat the wells with an acellular layer of collagen. The 
mixture was allowed to polymerize for approximately 1 h at 37 ˚C. CD4+ T cells 
were used at a concentration of 1x10
6 
cells/ml and PTEC at 1.5x10
5
 cells/ml for 
proliferation assays. For wells containing CD4
+
 T cells in gels, 200 µL of the cell 
suspension was transferred to an Eppendorf tube and centrifuged at 373 g for 5 
minutes. The supernatant was carefully removed completely and the cell pellet 
resuspended and mixed gently with chilled neutral collagen. The mixture was placed 
on top of the acellular layer of collagen at 50 µL/well. Where PTEC were cultured 
along with CD4
+
 T cells, 200 µL of PTEC was mixed with 200 µL of T cells and 
centrifuged at 373 g for 5 minutes. The mixtures were plated at 50 µL/well in 96 well 
plates and allowed to polymerize for approximately 1 hr at 37 ˚C in the incubator. 
After the gels have formed 200 µL CM was added to each well and proliferation 
assay was performed as described in section 3.11.
 
 
3.4. Digestion of gels 
PTEC and CD4
+
 T cells were harvested from the collagen matrix by digesting 
enzymatically with 1 mg/ml collagenase P (Roche, Mannheim, Germany) in the 
presence of 20 µg/mL DNase I (Roche) for 15-20 mins at 37 ˚C. Cells were washed 
once with PBS and resuspended in medium for further study. This digestion protocol 
was also utilised for GelMA gels. The dissolution of alginate-based gels was carried 
out by addition of 500 µL of EDTA to the gels. The gels were incubated for 10-15 
min to obtain cells. The cells were washed once in PBS at 373 g for 5 min before 
resuspending in CM for further study.   
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3.5. Flow cytometry  
3.5.1. Cell surface staining 
For surface staining of stimulated lymphocytes or PTEC, cells were washed 
once in FACS Buffer and subsequently incubated at 4 °C for 20 min with 30 μl of 
FACS Buffer containing appropriate dilutions of fluorochrome-conjugated antibodies 
or matched isotype controls optimised in our laboratory and previously published [3]. 
Briefly, recovered cells were resuspended in 30 μL FACS buffer (PBS + 0.5% 
bovine serum albumin (BSA) + 0.02% Sodium Azide) supplemented with 1 μL of 
each antibody and incubated at 4°C in the dark for 30 min. T cells were analysed by 
staining with fluorescein isothiocyanate (FITC), phycoerythrin (PE), and 
allophycocyanin (APC) conjugated monoclonal antibodies against CD4, CD69 and 
CD25 respectively. Conjugated mouse IgG1 and IgG2a served as isotype controls. 
For PTEC, cells were stained with APC and PE-Cy7 conjugated with monoclonal 
antibodies against HLA-DR and PD-L1 respectively. The isotype controls were 
conjugated mouse IgG1 and IgG2 antibodies. Following staining, the cells were 
washed in FACS Buffer and resuspended in 200 μl FACS Buffer for analysis within 
2 h or 1 % paraformaldehyde (PFA; Sigma) supplemented PBS for delayed analysis. 
For viability staining, cells were labelled with the dead cell stain Near-IR (Life-
technologies) according to the manufacturer‘s instructions and then acquired by flow 
cytometry. Viable cells stained negative for Near-IR.  
  
3.5.2. Flow Data acquisition and analysis 
Cell acquisition was carried out using BD Canto II flow cytometer (BD 
Biosciences) and analysis of flow data performed using FlowJo 10.1 (TreeStar).  
Expression of an antigen was measured as the ‗fold mean fluorescence 
intensity (MFI)‘, which is the change in MFI between a test antibody-stained sample 
and an isotype control-stained sample. 
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3.6. Expression of PD-L1 and MHC II PTEC cultured 
within 3D collagen gels 
The effects of the cytokines IFN-γ and TNF-α and both together on the 
expression of PD-L1 and MHC Class II on primary human PTEC were studied.  
Primary human PTEC (4x10
4 
cells/well) were cultured within 3D collagen gels 
(for gel making refer section 3.3.3) for 36 hours following exposure to the cytokines. 
Duplicate cultures were established in a 96 well flat-bottom plate. No cytokine was 
added to the first two wells and acted as the control. PTEC in the next duplicate wells 
were exposed to IFN- γ (100 ng/mL). In two other wells PTEC were exposed to 
TNF-α (20 ng/mL). The final duplicate wells were exposed to IFN-γ (100 ng/mL) 
and TNF-α (20 ng/mL) together. A 2D culture with a similar set up was established 
at the same time. DM was used for PTEC culture. 
After 36 hours, 2D cells were gently detached with TrypLE™ Express (1x) 
neutralized with trypsin inhibitor while 3D gels were digested (refer section 3.4) to 
harvest the cells. Cells were washed once in DM and re-suspended in FACS buffer 
for cell staining (refer 3.5.1) and acquired with flow cytometry. Data was analysed 
using FlowJo software.  
 
3.7. CFSE labelling of CD4+ T cells  
To enable live cell imaging and to monitor cell division, freshly isolated CD4
+
 
T cells (refer 3.2.12) were labelled with carboxyfluorescein diacetate succinimidyl 
ester (CFSE). Briefly, 1 µM CFSE was prepared in PBS and an equal volume of cell 
suspension diluted to 2 x 10
6 
cells/ml in PBS was added to it. The mixture was 
vortexed and incubated at room temperature for 5-10 mins with occasional shaking. 
After incubation, an equal volume of FCS was added to the mixture and centrifuged 
at 1400 rpm for 5 mins. Cells were then washed twice with RPMI-10 % FCS, 
counted in a haemocytometer (refer 3.2.13) and encapsulated in GelMA (refer 3.3.2) 
or collagen (refer 3.3.3) for live imaging. 
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3.8. Time-lapse video microscopy 
Time lapse movements of PTEC and CFSE labelled CD4
+
 T cells embedded in 
different types of gel constructs were recorded over a period of 20 hours or more 
using the Cell Voyager CV1000 Confocal Scanner Box (Yokogawa Electric 
Corporation). Live images of the cells were captured every 10 minutes using both 
brightfield and fluorescence channels. Z-stack (~ 7 μm z-steps) images were 
obtained. 
Cells were tracked using the manual tracking option of Image J software (NIH, 
USA). The displacement of a cell was calculated by subtracting the positions 
between two time points.  
 
3.9. Cell Viability in different gel models 
To evaluate cell viability, PTEC and T cells encapsulated in gels were stained 
with fluorescein diacetate (FDA) for live cells and propidium iodide (PI) (both 
Invitrogen) for dead cells. Hydrogel constructs were transferred into a new 48 well 
plate and washed in PBS for 5 min at 37 °C. The gels were then incubated in PBS 
containing 10 μg/mL FDA and 5 μg/mL PI for up to 45 min at 37 °C and washed 
again with PBS for 5 min. Images were taken with either a confocal (Leica 
Microsystems, Wetzlar, Germany) or an Olympus microscope. 
 
3.10. PTEC and CD4+ T cells staining on GelMA 
PTEC seeded on GelMA gels were grown for 28 days. At day 28, the gels were 
removed from the media, cut in half and transferred into 48 well plates. After 
fixation with 500 µL 4% paraformaldehyde (PFA) for 20 mins at room temperature 
the gels were washed twice with PBS for 5 mins and the cells within the gels were 
stained for different markers as follows: 
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3.10.1. Staining with vimentin antibody, DAPI (4′, 6-diamidino-
2-phenylindole dihydrochloride) and PNA (lectin- peanut 
agglutinin)  
As we would expect cells to undergo epithelial to mesenchymal transition (EMT) in 
long term cultures, PTEC cultured for 4 weeks on gelMA were tested for EMT by 
staining with vimentin.  
For intracellular staining of vimentin, cells within gels were permeabilized by 
incubating with PBS containing 0.1 % Triton-X100 for 20 mins. Next, gels were 
washed for 5 min with PBS and 250 µL of primary antibody solution was applied. 
The primary antibody solution constituted of mouse anti-human vimentin antibody 
(IgG1κ) final concentration 4.9 µg/mL in 3 % (v/v) donkey serum/PBS. After an 
hour of incubation at RT, samples were washed twice with 500 µL of PBS for 5 mins 
on a shaker. Secondary antibody solution comprising of DAPI (final concentration 5 
µg/mL), Alexa Fluor® 488 –labelled donkey anti-mouse antibody (final 
concentration 4.7 µg/mL) and PNA (final concentration of 20 µg/mL) in 3 % donkey 
serum/PBS was added to gels for 1 hour in the dark. At the end of incubation time, 
gels were washed twice in ice-cold PBS for 5mins on a shaker and images taken on a 
confocal microscope (SP5 Leica). 
 
3.10.2. Staining with rhodamine phalloidin, DAPI and PNA 
Following fixation, gels were incubated with 250 µL antibody solution comprising of 
DAPI (final concentration 5 µg/mL) rhodamine phalloidin (0.8 U/mL) and Alexa 
fluor ® 647 labelled lectin PNA (20 µg/mL) in PBS. After an hour of incubation at 
room temperature (RT), samples were washed twice with 500 µL of PBS for 5 mins 
on a shaker and images taken on a confocal microscope (SP5 Leica). 
 
3.10.3. Staining with collagen IV antibody, E-cadherin antibody 
and DAPI 
After the gels were fixed and washed in PBS, a solution of primary antibodies 
against E-cadherin (1 in 200 dilution) and collagen IV (3.5 µg/mL) in PBS 
containing 3% donkey serum was added to the gels and incubated at RT for 1 hour. 
Next, samples were washed twice with PBS for 5 mins on a shaker before a 
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secondary antibody mix of DAPI (final concentration 5 µg/mL), Alexa Fluor ® 594 
– labelled donkey anti–rabbit secondary antibody and Alexa Fluor ® 488 – labelled 
donkey anti-mouse antibody (both at final concentration 4.7 µg/mL) was applied to 
the gels. Gels were incubated 1 hr in dark at RT and washed twice with ice cold PBS. 
Images were taken on a confocal microscope (SP5 Leica). 
 
3.11. Proliferation assays 
2D cultures were established in flat-bottom 96-well plates with CD4
+
 T cells at 
2 × 10
5
/ well with or without IFN-γ-activated (100 ng/mL), irradiated (30 Gy) PTEC, 
at a concentration of 1.5 × 10
5
/mL.  
For 3D cultures, an acellular layer of collagen type I was laid to the bottom of 
wells of a 96 flat-bottom plate. The same number of CD4
+
 T cells and PTEC were 
mixed with 50 µL of collagen solution and added to the appropriate wells (refer 
section 3.3.3). CM was added to all wells. Cultures were established in triplicate with 
the following stimulator concentrations: phytohaemagglutinin (PHA) 20 μg/mL, 
mouse anti-human CD3 clone CLB-T3/4.E (αCD3) 0.5 μg/mL and mouse anti-
human CD28 clone CLB-CD28/1 (αCD28) 0.1 μg/mL. Cultures containing PHA and 
αCD3/28 were incubated for 3 days at 37 °C in 5 % CO2. Proliferation was assessed 
by the addition of 1 μCi 3H-thymidine/ well for the last 8 h of cultures. 3D gels were 
dissolved (refer section 3.4) and cells were harvested using a Skatron Cell Harvester. 
Results are expressed as a stimulation indices (SI), obtained by dividing means of 
triplicate test wells by means of relevant triplicate no stimulation control wells. 
 
3.12. PTEC-T cell blocking studies 
In order to identify the mechanism behind the immuno regulatory role of 
autologous PTEC, surface molecules such as PD-L1 and intracellular IDO were 
neutralised within the PTEC-T cell co-cultures. In 2D cultures and 3D cultures,       
PD-L1 was blocked by addition of 10 μg/mL of anti-human PD-L1 (Bio legend, San 
Diego) blocking antibody to the surface of PTEC and incubated for 2 h at 37ºC. 
Following incubation, the PTEC wells were washed to remove excess antibody and 
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the co-cultures were established as described in section 3.11. To neutralise IDO, 
1500 μM/mL IDO inhibitor 1-MT was added into the PTEC or control wells 
following the set-up of co-cultures.  
3.13. Chemokine Analysis 
Chemokines CXCL8/IL-8, CCL5/RANTES, CXCL9/MIG (Monokine induced 
by gamma interferon), CCL2/MCP-1 and CXCL10/IP-10 (Interferon gamma-
induced protein 10) were analysed from PTEC culture supernatants using Cytometric 
Bead Array Human chemokine kit (BD Biosciences) according to manufacturer‘s 
instructions. Briefly, standard chemokine dilutions were performed as per 
instructions in the manual. 50 µL of standard solutions and samples were added to 
different wells of a 96 well U-bottom plate. To these wells 50 µL of mixed capture 
beads were added. This was followed by addition of 50 µL of Human Chemokine PE 
Detection Reagent to the wells. The plate was incubated for 3 hours at RT, protected 
from light. Each well was topped-up with 150 µL of wash buffer and centrifuged at 
200 x g for 5 min. The supernatant was discarded and pellet was resuspended in 100 
µL of wash buffer. Samples and standards were acquired using FACS array (BD 
Biosciences). Data analysis was done on FCAP array software (BD Biosciences). 
 
3.14. Cytokine Analysis 
3.14.1. Human Inflammatory Cytokines 
Human inflammatory cytokines IL-8, interleukin-1-β (IL-1β), interleukin-6 
(IL-6), interleukin-10 (IL-10), tumor necrosis factor (TNF) and interleukin-12p70 
(IL-12p70) within supernatants from 2D and 3D cultures were measured using 
Cytometric Bead Array Human Inflammatory cytokines kit (BD Biosciences) 
according to manufacturer‘s instructions (section 3.13).  
 
3.14.2. Human Th1/Th2 Cytokine Kit II 
Human Th1/Th2 cytokines interleukin-2 (IL-2), interleukin-4 (IL-4), IL-6, IL-
10, TNF and IL-12p70 within supernatants from 2D and 3D cultures were measured 
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using Cytometric Bead Array Human Th1/Th cytokine kit (BD Biosciences) 
according to manufacturer‘s instructions (section 3.13).  
 
3.15. Collaborations 
A/Prof. Travis Klein and Dr. Karsten Schrobback from IHBI at QUT have 
collaborations with Dr. Ray Wilkinson from the Conjoint Renal Research Lab at 
QIMR Berghofer to work on this project together using facilities available at both 
IHBI and QIMR Berghofer. Dr. Helen Healy (Head of Renal Research Lab) and Dr. 
Ray Wilkinson from the Conjoint Renal Research Laboratory, Queensland Health 
have approval to obtain kidney tissue and blood from patients undergoing 
nephrectomies at the Royal Brisbane and Women‘s Hospital, Wesley Hospital.  
 
3.16. Statistical Analysis 
Comparisons between groups were performed using two-tailed t-test. Statistical 
tests were performed using GraphPad Prism 6.0 analysis software (GraphPad, San 
Diego, CA). P-values ≤ 0.05 were considered statistically significant. 
 
3.17. Ethics and Limitations 
This project had ethics approval from The Queensland Institute of Medical 
Research - Human Research Ethics Committee (QIMR-HREC Ref. No. P293), The 
Royal Brisbane and Women‘s Hospital -Human Research Ethics Committee 
(RBWH-HREC Ref. No. 2002/011), Queensland Health-Pathology (Ref. No. 
P293RB) and the Wesley Research Hospital Tissue Bank.  
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Chapter 4: Results  
4.1. Defining a 3D matrix suitable for PTEC and T cell 
co-culture. 
4.1.1. Gel mixtures as a matrix to co-culture PTEC and CD4+ T 
cells. 
 
Various hydrogels and hydrogel combinations were examined to define a suitable 
matrix for 3D culture of PTEC and CD4
+
 T cells. To increase matrix stiffness and 
improve handling, alginate was added to either collagen or Matrigel. These 
mixtures of gels were then used to encapsulate CD4
+
 T cells and viability of cells 
was checked at different time points.  
Live-dead staining of CD4
+
 T cells at 24 hours into culture indicated that the 
alginate only gels had lower viability compared to the alginate-collagen and 
alginate-matrigel gels (Figure 4.1). 
 
At 24 hrs into culture, CD4
+
 T cells within the different gel types were stained with fluorescein 
diacetate (FDA) and propidium iodide (PI) to detect live (green) and dead (red) cells. Cells 
encapsulated within alginate only gel had lower viability compared to the alginate-collagen and 
alginate-matrigel gels. 
 
Figure 4.1 Live and dead staining of encapsulated CD4+ T cells in different combinations 
of gels.  
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The alginate-collagen and alginate–matrigel gels were cultured for a week and 
stained for live and dead cells. Images taken at day 7 after staining demonstrated a 
major decrease in viability in both alginate-collagen gel and alginate-matrigel gel 
compared to day 1 ( Figure 4.2). 
 
The cells were stained with fluorescein diacetate (FDA) and propidium iodide (PI) to detect 
live (green) and dead (red) cells.  
 
4.1.2. Gelatin methacrylamide (GelMA) as a 3D matrix to co-
culture PTEC and CD4
+
 T cells. 
 
4.1.2.1. PTEC attachment and viability on GelMA hydrogel 
GelMA hydrogel has been shown to be able to sustain long term viability of 
different cell types [110, 115].  
To demonstrate whether GelMA is a suitable hydrogel to sustain PTEC, 
these cells were seeded on 5% GelMA and cultured for 8 days. Images were taken 
at day 8 with a brightfield microscope. In 3D culture formation of network and 
tubule-like structures were seen whereas in 2D cultures the cells formed a 
confluent monolayer of cells Figure 4.3. 
Figure 4.2 Live and dead staining of encapsulated purified CD4+ T cells in different gels 
after 7 days in culture.  
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Figure 4.3 (A) PTEC at day 8 in 2D culture (B) PTEC in 3D culture (seeded on 5 % 
GelMA) at day 8. 
Formation of networks and multicellular structures (black arrows) were seen in 3D culture. 
Images were taken with Olympus CK40 (Scale bar = 100µm). 
 
Purified CD4
+
 T cells were encapsulated in 5% GelMA and PTEC were seeded on 
the GelMA hydrogel. Following 4 weeks in culture, the cells were stained for 
actin filaments (phalloidin-green), glycosylated proteins (peanut agglutinin-red) 
and nuclei (DAPI-blue). Confocal images were taken at day 28. Figure 4.4Error! 
eference source not found. shows network formation by PTEC on GelMA. 
However, no T cells were detected within the GelMA at day 28. 
 
 
 Figure 4.4 Confocal image of 
purified CD4+ T cells and PTEC 
on GelMA 3D at day 28. 
Cells are stained for actin 
filaments (phalloidin-green), 
glycosylated proteins (Peanut 
agglutinin-red) and nuclei 
(DAPI-blue). No Live T cells 
were detected. 
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PTEC on GelMA 3D hydrogel cultures stained positive for epithelial cell marker 
E-cadherin, which were visualised with confocal immunoflourescence, with 
nuclei stained with 4‘, 6-diamidino-2-phenylindole (DAPI) Figure 4.5.  
 
Figure 4.5 PTEC expressed typical epithelial cell markers on GelMA 3D hydrogel 
cultures which was visualised with confocal immunofluorescence.  
 
 
 
PTEC grown on the GelMA surface remained viable for at least 4 weeks in 
culture forming networks and spreading to cover the hydrogel surface. 
 
4.1.2.2. Effect of brief UV exposure on CD4+ T cells. 
The ability of CD4
+
 T cells to migrate and remain viable within GelMA hydrogels 
was examined. GelMA requires approximately 5 minutes of ultraviolet (UV) 
radiation to form a gel. To test the effect of UV exposure on CD4
+
 T cell viability, 
purified CD4
+
 T cells were added to a glass slide chamber and exposed to UV for 
5 mins. A control was set up by adding an equal number of purified CD4
+
 T cells 
into another glass slide chamber. Viability of the cells at different time points was 
tested by staining the cells with a Near Infrared (IR) dye and analysing using flow 
cytometry.  As shown in  Figure 4.6, the flow cytometry profile (A & B) of the T 
(A) PTEC stained positive for E-cadherin (red) and nuclei (DAPI-blue) , collagen IV (green), 
(B) PTEC stained positive for vimentin (green), PNA (red) and nuclei (DAPI-blue), (C) 
Phalloidin (green), PNA (red) and DAPI (blue). 
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cells at day 3 suggested that 5 min UV exposure does not affect viability of CD4
+
 
T cells. The percentage viability of both the control and UV-exposed T cells          
( Figure 4.6 C ) was similar over 6 days.  
 
 
  
 Figure 4.6 Effect of brief UV exposure on CD4
+
 T cell viability 
 
 
 
  
A) Typical flow cytometry profile from control and (B) UV-exposed CD4
+
 T cells at day 
3. (C) Control CD4
+
 T cells (grey bars) and cells exposed to UV for 5 min (black bars) 
were cultured in complete media for 6 days and their viability monitored at days 1, 3 and 
6 by staining with the viability dye Near IR (stains dead cells) and analysing using flow 
cytometry. Data shows results of n=1. 
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4.1.2.3. Ability of encapsulated CD4+ T cells to remain viable and migrate 
within GelMA. 
 
The ability of encapsulated T cells to successfully migrate within GelMA gel was 
studied. T cells are highly motile cells that constantly circulate in the blood. These 
cells migrate into different organs in response to injurious stimuli to mediate 
immune responses. 
Time lapse photography of CD4
+
 T cells (labelled with CFSE) within 
GelMA gel over a period of 20 hours demonstrated no movement of T cells 
through the gel (Figure 4.7). 
 
 
Figure 4.7 Live cell images of CD4+ T cells in GelMA gel. 
Freshly isolated CD4+ T cells were pre-labelled with CFSE and encapsulated in GelMA. 
Time lapse photography of CD4+ T cells (green) in GelMA gel over a period of 20 hours 
shows no T cell movement through the gel. 
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The number of viable CD4
+
 T cells over time in GelMA was estimated based 
on CFSE staining. CFSE positive cells were counted in one field of the images. 
Images were taken every 10 mins and 28 live T cells were present in the field 
at start. Figure 4.8 suggests that the number of live CD4
+
 T cells in GelMA 
declined over time.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To further confirm the findings, PTEC and T cells were encapsulated within 5 
% GelMA gel and their viability examined at day 5. Figure 4.9 shows that 
PTEC remained viable when encapsulated within GelMA but all CD4
+
 T cells 
were dead after 5 days in culture within the GelMA culture model. 
 
 
 
Figure 4.8 Viability of CD4+ T cells in GelMA gel. 
Viability of encapsulated T cells was determined from the live images captured using a 
confocal microscope (Cell Voyager CV-1000). Purified CD4+ T cells were CFSE labelled 
before encapsulating within GelMA. Images were taken every 10 mins using the 
fluorescence channel. Based on CFSE staining, cells were counted from one field of image. 
Number of live T cells in the field was 28 at start but this decreased over time. 
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The cells differentiated by size were stained with fluorescein diacetate (FDA) and propidium 
iodide (PI) to detect live (green) and dead (red) cells. Images were taken at day 5 using 
Olympus IX81. 
 
Figure 4.9 PTEC and CD4+ T cells encapsulated in GelMA. 
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4.1.3. Collagen type I as a matrix for co-culture of PTEC and 
CD4
+
 T cells. 
Collagen is one of the vital components of the ECM in natural tissue. To 
successfully use collagen as a matrix for co-culturing of autologous primary 
human PTEC and immune cells, the ability of T cells to migrate and interact with 
PTEC within collagen was examined. 
T cell migration within collagen gel was assessed by performing live–cell 
imaging. Time lapse video-microscopy of encapsulated T cells showed that T 
cells were capable of effectively migrating through the gel (refer video 1). Figure 
4.10 shows T cell movement through collagen using manual tracking (Image J 
software) over a period of 20 hours.  
 
 
 
Figure 4.10 Encapsulated T cell movement through collagen gel. 
T cells were pre-labelled with CFSE and encapsulated within collagen gels and imaged 
live over 24 h using the CV1000 Confocal Scanner Box (Yokogawa Electric 
Corporation). Cells were tracked using Image J software. The paths followed by 
individual T cells are plotted as colored lines. The different images show different T 
cells tracked within the same gel. When a particular T cell disappeared from the field 
its path was omitted in the succeeding images.  
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To evaluate the capability of PTEC to move through the collagen gel, PTEC were 
encapsulated within collagen and imaged live (with CV 1000 Confocal Scanner 
Box, Yokogawa Electric Corporation) over 24 hours. PTEC tracking within 
collagen gel using Image J software (Figure 4.11) revealed that these cells were 
capable of spreading and multiplying (seen in videos taken beyond 24 h, data not 
shown here) within collagen. 
 
 
 
The next objectives were to record movements of T cells in presence of PTEC and 
visualize their interactions within collagen gels. To accomplish this, PTEC and T 
cell were encapsulated within collagen gels together and their time lapse 
movement recorded over 24 hours. Images showed that both cell types were 
capable of moving through the gel and interacting with each other. When T cells 
were tracked in presence of PTEC within collagen gels (Figure 4.12) their 
movement within the gel appeared to some extent restricted when compared to 
movement of T cells alone within collagen. In order to investigate this further, 
two separate analyses were undertaken.  
PTEC were encapsulated within collagen gels and imaged live over 24 h using the CV1000 
Confocal Scanner Box. Cells were tracked using Image J software. Ten individual PTEC 
were tracked within the collagen gel and colored lines indicate paths followed by PTEC 
over 24 h. 
Figure 4.11 PTEC  movement through collagen. 
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Mean T cell displacements in absence or presence of PTEC were plotted as a 
function of the square root of time. A plot of mean displacement of cells against 
the square root of time provides some information about the type of migration that 
is involved. Results from this methodology are presented in Figure 4.13. 
However, from these results it is difficult to interpret whether the migration 
represents a ―random walk‖ or a directional movement. What can be inferred from 
the results presented in Figure 4.13 is that in the presence of PTEC T cells 
displayed an obvious restricted mobility, suggesting cellular interaction [123].  
 
 
 
 
 
PTEC and CD4+ T cells were encapsulated within collagen gels and imaged live using CV 
1000 Confocal Scanner Box. T cells were tracked using Image J software. The paths followed 
by individual T cells are plotted as colored lines. The two images show different T cells 
tracked within the same gel. When a particular T cell disappeared from the field its path was 
omitted in the succeeding images.  
Figure 4.12 T cell tracking within collagen gels in presence of PTEC. 
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Figure 4.13 Mean displacement of T cells in absence and presence of PTEC within 
collagen gels. 
 
The second methodology utilised a track plot of T cell movement to obtain a 
qualitative indication of cell movement and directionality. This track plot is 
plotted by shifting the origin of each individual cell to the same point in space 
without changing their orientation. The plot also helps to roughly determine 
whether cells are undergoing a directional movement or a ―random walk‖. A plot 
in which all possible directions of migration are covered is indicative of random 
movement [123]. Figure 4.14 shows the track plots for T cells encapsulated 
within collagen in absence and presence of PTEC. The graphs are indicative of a 
random movement within the gel in absence of PTEC. However, in presence of 
PTEC, the plot suggests a preferred directional migration. 
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The time lapse images from the videos (refer video 2) illustrated that T cells and 
PTEC within the collagen gel culture model were capable of moving through the 
gel. T cells moved rapidly through the gel and interacted with PTEC. The 
interactions arrested the movement of the T cells for a time span ranging from 2-4 
hrs approximately. T cells migrated away from the PTEC after the interaction. 
Figure 4.15 shows snapshots from a time lapse video illustrating movement and 
interactions of T cells and PTEC within the collagen culture model. 
 
  
Figure 4.14  A track plot with tracks being shifted to start at the origin of x and y axes 
(A) shows the tracks followed by T cells within the collagen gel in absence of PTEC (B) 
shows track plots of T cells in presence of PTEC when both cells were encapsulated 
within the collagen gel. 
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Figure 4.15 Snapshots from time lapse videos showing interactions and movement of T cells 
and PTEC within collagen gels. 
PTEC and T cells (pre-labelled with CFSE) were encapsulated within collagen gels and live-cell 
imaging was performed for 24 h using CV1000 confocal scanner box. Black arrows indicate PTEC 
and T cells that had interactions. 
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4.1.4. Summary 
Previously the interactions between autologous PTEC and T cells were 
studied using 2D static in vitro cultures. In an attempt to design a 3D in vitro 
model to investigate the interactions of these two types of cells under a more 
physiologically relevant condition, various types of 3D cell culture models were 
investigated. 
In the first instance, alginate and CD4
+
 T cell interactions were monitored. 
Alginate gels are to some extent similar to ECM in tissues but lack cell adhesion 
sites and allow no interaction between the gel and the cells [92]. I found that a 
significant number of encapsulated T cells died within the first 24h. To add 
adhesion sites for the cells within alginate gel, it was either mixed with collagen 
or Matrigel. T cells were then encapsulated into mixtures of alginate-collagen and 
alginate–matrigel and cultured for a week. Live/Dead staining of cells in these 
gels at day 7 indicated that there were again numerous dead cells. All the results 
suggested that alginate gel or mixtures of alginate gels with ECM-based materials 
were not suitable for the long-term maintenance of human T cells.  
Next GelMA hydrogel was examined as a possible ECM for co-culturing 
PTEC and T cells. PTEC showed promising results when cultured on GelMA 
hydrogel. Following a week of PTEC culture on GelMA the cells formed 
networks and multi-cellular structures in the 3D model. PTEC also expressed 
epithelial cell marker when cultured for 4 weeks on GelMA. As GelMA is a 
photo-cross linkable gel the effect of brief UV exposure on the T cell viability 
within GelMA was examined. Results suggested that brief exposure of UV does 
not affect viability of T cells within GelMA. However, the ability of T cells to 
migrate within GelMA appeared restricted and T cells were incapable of 
migrating through the 3D GelMA culture model. 
Collagen is one of the vital components of the ECM. Research has shown 
that the pattern of migration of leukocytes in 3D collagen closely resembles the in 
vivo leukocyte migration in peripheral tissues. [124]. In this thesis collagen was 
next tested as a potential 3D matrix for the co-culture of cells. Within this 
collagen model, T cells were capable of migrating through the gel. PTEC were 
able to migrate and spread within the collagen gel. The collagen gel model was 
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able to sustain both the PTEC and T cells and there were interactions between T 
cells and PTEC. 
4.2. Activated PTEC modulate CD4
+
 T cell responses in a 
3D in vitro model 
4.2.1. Expression of activation markers on CD4+ T cells in 3D 
collagen culture  
 
The expression of activation antigens on CD4
+
 T cells within collagen gels was 
monitored. CD4
+
 T cells were stimulated with anti-CD3/28 in gels and after 3 
days in culture, the gels were dissolved and recovered T cells stained for surface 
expression of CD69 and CD25 antigens. The cells were analysed using flow 
cytometry. CD4
+
 T cells increased the expression of their activation markers 
within collagen gel following stimulation (Figure 4.16). Minimal to no expression 
of activation markers CD69 and CD25 were seen on unstimulated CD4+ T cells. 
 
 
 
 
 
Figure 4.16 Expression of activation markers CD69 and CD25 on CD4 +  T cells in 3D 
collagen gels after being stimulated with anti-CD3/28. 
(A) Forward and side scatter profiles of CD4 + T cells extracted from 3D gels. (B) 
Expression of CD69 and (C) expression of CD25 on T cell surface extracted from 3 D gels.    
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4.2.2. Surface antigen expression of PTEC in the presence of 
inflammatory cytokines in 2D and 3D in vitro cultures. 
 
Initially, PTEC from one donor were cultured for 36 h in a 3D collagen gel culture 
system in the presence of 100 ng/mL gamma-interferon (IFN-γ), 20 ng/mL of 
tumour necrosis factor (TNF-α) and a combination of 100 ng/mL IFN-γ and 20 
ng/mL of TNF-α to determine whether these cells could up-regulate their surface 
expression of PD-L1 and MHC class II (HLA-DR). After 36 h, gels were digested 
and the recovered cells stained for these antigens. Results demonstrated that there 
was maximum up-regulation of these antigens in response to IFN-γ and TNF-α 
combined (Figure 4.17), confirming that PTEC within 3D collagen gels were 
capable of up-regulating their surface antigen expression.  
 
Our group has previously demonstrated, using 2D culture, that IFN-γ exerts a 
major up-regulation of PD-L1 and HLA-DR expression on primary human PTEC 
Figure 4.17 Inflammatory cytokine induced PD-L1 and HLA-DR expression on primary 
PTEC cultured using the 3D in vitro model.  
 A and B shows the expression of HLA-DR and PD-L1, respectively, in a representative 
donor. PTEC were encapsulated within collagen gels and cultured for 36 h in presence of 100 
ng/mL gamma-interferon (IFN-γ) , 20 ng/mL of tumour necrosis factor (TNF-α) and a 
combination of 100 ng/mL IFN-γ and 20 ng/mL of TNF-α in different wells. After 36 h the 
gels were digested to recover the cells. PTEC were next stained for PD-L1 and HLA-DR and 
surface expression checked by flow cytometry.  
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[3]. Therefore, the differences of surface antigen expression of PTEC cultured in 
2D and 3D systems were then compared. Primary human PTEC from two 
different donors were subjected to 36-h exposure to the inflammatory cytokines in 
2D and 3D cultures. As seen in Figure 4.18, the delta mean fluorescence intensity 
(∆MFI) for the expression of PD-L1 and HLA-DR suggested that in both the 
donors there were higher expressions of these molecules on activated PTEC in 3D 
as opposed to 2D cultures.  
 
Surface expression was measured by flow cytometry (gated on single, live cells) and 
expressed as the delta mean fluorescence intensity (∆MFI) (MFI of test samples - MFI of 
isotype control). ∆MFI for the expression of PD-L1 and HLA-DR is shown for donor 1 in A 
and B respectively and for donor 2 in C and D respectively. 
 
 
Figure 4.18  PTEC from two donors were stained for the expression of PD-L1 and Class II 
(HLA-DR) following 36 h exposure to 100 ng/mL gamma-interferon (IFN-γ), 20ng/mL of 
tumour necrosis factor (TNF-α) and combination of 100 ng/mL IFN-γ and 20 ng/mL of 
TNF-α. 
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4.2.3. Modulation of proliferative responses by autologous PTEC 
in 2D and 3D. 
Next, the ability of activated autologous PTEC to modulate the proliferation of 
purified CD4
+
 T cells in response to PHA and anti-CD3/CD28 was compared 
using 2D and 3D in vitro cultures. The proliferation assay was repeated using 6-7 
donors. Figure 4.19 shows a greater down-modulation of CD4
+
 T cell 
proliferation occurred within 3D cultures than those within 2D cultures. This 
result may provide support for the hypothesis that 3D culture models provide a 
more realistic in vivo environment than 2D cultures.  
 
Figure 4.19 Activated PTEC suppressed proliferative responses of autologous T cell 
populations. 
Activated PTEC suppress proliferative responses of autologous T cell populations. (A) and (B) 
show the means of 6 separate experiments ±1 SEM in 2D and 3D cultures respectively and (C) 
shows the results from all six donors in response to PHA in the 3D culture. (D) and (E) show the 
means of 7 experiments ±1 SEM in 2D and 3D cultures respectively and (F) shows the results of 
all seven donors in response to anti-CD3/CD28 in 3D culture. Results are expressed as 
Stimulation index (SI), obtained by dividing means of triplicate test wells by means of relevant 
triplicate no stimulation control wells. Statistical comparisons between two groups were 
performed using a two tailed t –test. * P ≤ 0.05 when compared with no added PTEC. 
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4.2.4. Down-modulation of immune cell responses by activated 
autologous PTEC is partially mediated by PD-L1 in 3D 
cultures. 
A previous paper published by our laboratory has demonstrated that in 2D 
cultures, down-modulation of immune cell responses by autologous activated 
PTEC is partially mediated by PD-L1 [3]. 
To examine the role of this molecule in immune-regulation within our 3D 
cultures, blocking studies were performed by addition of anti-PD-L1 (clone 
29E.2A3) antibody (Ab) to PTEC encapsulating in the gels. The addition of anti-
PD-L1 Ab showed partial recovery of proliferation in 3D co-culture experiments 
compared to the inhibition seen in the presence of PTEC without the blocking 
antibody (Figure 4.20). 
 
 
 
 
Further work to investigate the mechanisms by which PTEC down-modulates T 
cell proliferative responses are being currently undertaken in our laboratory.  
In proliferation experiments performed using 3D cultures; blocking antibody to PD-L1 at 
10µg/mL was added to irradiated autologous activated PTEC for 2 hours. Following Ab 
removal, PTEC were incorporated within collagen gels with purified autologous CD4
+
 T 
cells to perform proliferation assays. Figure shows CD4
+
 T cell responses for 3 separate 
donors to 40µg/mL phytohaemagglutinin (PHA). White bars represent no PTEC, black 
bars indicate presence of activated, irradiated (30 Gy) autologous PTEC and grey bars 
PTEC pre-treated with anti-PD-L1 antibody. Results are expressed as Stimulation index 
(SI), obtained by dividing means of triplicate test wells by means of relevant triplicate no 
stimulation control wells. 
Figure 4.20.  PD-L1 partially mediates activated PTEC immune modulation in 3D in 
vitro autologous cultures. 
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4.2.5. Role of IDO in immune modulation of autologous T cells 
Research using mouse models has shown that mouse renal epithelial cells 
are capable of producing the intracellular enzyme indoleamine 2, 3-dioxygenase 
(IDO) in response to the inflammatory cytokines IFN-γ / TNF-α [65]. Previous 
studies reported there is a co-relation between IDO expression and Chronic 
Kidney Disease [66]. IDO is a tryptophan–catabolising enzyme and has immune 
suppressive effects on T cell functions [46]. 
Our own unpublished results from the laboratory have demonstrated a 
partial role for this molecule in immune-modulation in 2D liquid cultures. An 
initial experiment was undertaken with a single donor sample to assess the role of 
IDO within a 2D and 3D culture system. The IDO blocking reagent 1-MT was 
added to facilitate this. Results (presented in Figure 4.21) demonstrated at least a 
partial role for IDO in our observed immune-modulation and there was an 
additive recovery of proliferation when both PD-L1 and IDO were blocked in the 
same culture.  Due to limited donor samples towards the end of this project, 
experiments with IDO blocking were confined to only 2 more donor samples 
within a 3D culture system. Donor 2 showed a similar response to that observed in 
A B 
Proliferation experiments were performed in 2D (control) and 3D cultures. In 2D and 3D 
cultures, blocking antibody to PD-L1 was added to irradiated (30 Gy), activated autologous 
PTEC at 10 µg/mL for 2 h. In 2D cultures, after removal of Ab, CD4
+
 T cells were added.  In 
3D cultures, following Ab removal, PTEC were incorporated within collagen gels with 
purified autologous CD4
+
 T cells to perform proliferation assays.  1MT at 1500 µM/mL was 
added to PTEC- T cell co-cultures in 2D and 3D. (A) shows CD4
+
 T cell responses for one 
donor to 40 µg/mL phytohaemagglutinin (PHA) (B) T cell responses for the same donor to 
(0.5/0.1 µg/mL)  anti-CD3/CD28. Results are expressed as Stimulation index (SI), obtained by 
dividing means of triplicate test wells by means of relevant triplicate no stimulation control 
wells. 
 
Figure 4.21. Effect of blocking PD-L1 and IDO (using 1MT) on PTEC in 2D and 3D in vitro 
cultures in a representative donor.  
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Donor 1, with some recovery of proliferation in the presence of blocking to both 
PD-L1 and IDO (Figure 4.22 A and B). Whilst Donor 3 demonstrated no 
recovery in proliferation with blocking of either/both PD-L1 and IDO, possibly 
due to donor variability/genetics.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A B 
Proliferation experiments were performed in 3D in vitro cultures. Blocking antibody to PD-L1 
was added to irradiated (30 Gy), IFN-γ activated autologous PTEC at 10 µg/mL for 2 h. 
Following Ab removal, PTEC were incorporated within collagen gels with purified autologous 
CD4
+
 T cells to perform proliferation assays.  1MT at 1500 µM/mL was added to PTEC- T cell 
co-cultures. Figure 4.22 (A) shows CD4
+
 T cell responses for one donor to 40 µg/mL 
phytohaemagglutinin (PHA) (B) T cell responses for the same donor to (0.5/0.1 µg/mL) anti-
CD3/CD28. (C) and (D) shows the results from a third donor in response to PHA and anti-
CD3/CD28 respectively in 3D cultures. Results are expressed as Stimulation Index (SI), obtained 
by dividing means of triplicate test wells by means of relevant triplicate no stimulation control 
wells. 
 
Figure 4.22 Blocking of PTEC with anti-PD-L1 antibody and 1MT in 3D in vitro cultures. 
C 
D 
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4.2.6. Summary 
3D in vitro cultures enable cells to show appropriate cell responses that 
closely resemble their native behaviour. In 2D cultures, primary human PTEC 
cells of the kidney up-regulate surface antigens in response to inflammatory 
cytokines and are able to down-modulate autologous T cell proliferative 
responses. Previous blocking studies carried out using 2D cultures confirmed that 
this down-modulation of immune responses by activated autologous PTEC is 
partially mediated by PD-L1. 
A 3D in vitro model to study the PTEC- T cell interactions revealed that 
under inflammatory disease settings PTEC are capable of up-regulating surface 
antigen expression. The inflammatory cytokine IFN-γ has a profound effect on the 
surface expression of PD-L1 and MHC Class II (HLA-DR). TNF-α by itself does 
not cause any up-regulation of these antigens but can induce a much higher up-
regulation of PD-L1 and HLA-DR on PTEC surfaces in conjunction with IFN-γ. 
In the 3D cultures a higher expression of these antigens was seen compared to the 
2D control. 
 Comparisons of 3D and 2D models revealed enhanced modulation of T cell 
proliferative responses in 3D compared to 2D. As seen from the results, even 
within a small sample size, a significant down modulation of T cell proliferative 
responses was observed in 3D in vitro culture. Although a down-modulation in 
the presence of autologous PTEC in 2D was also seen within this sample size it 
was not significant, reiterating that 3D cultures allow PTEC to more effectively 
down modulate immune responses.  
PD-L1 is a strong co-inhibitory molecule up-regulated on primary human 
PTEC under conditions that mimic immunological signalling. The addition of 
blocking Ab to PD-L1 in 3D and 2D (control) culture systems affirmed that PD-
L1 plays a partial role in the down-modulation of T cell proliferation. Another 
mechanism proposed for inhibition of proliferation by PTEC was by IDO 
expression. In my cultures, IDO activity was blocked by addition of 1-MT. 
Results from the 3D cultures demonstrated a partial recovery of inhibition with 
IDO blockade in two out of three donors. Such donor to donor variability is 
commonly observed in an out-bred human cohort. 
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4.3. Chemokines and cytokines produced by PTEC. 
4.3.1. Chemokines produced by PTEC 
Under diseased conditions, PTEC produce a range of chemokines known to 
be chemotactic to monocytes, T cells, DC and neutrophils and these chemokines 
are up-regulated in response to inflammatory mediators like IFN-γ, TGF-β and 
TNF-α. Using a 2D culture system, the chemokines produced by PTEC in 
presence of IFN-γ (100 ng/mL) and TGF-β (20 ng/mL) were studied. Figure 4.23 
shows the mean +/- SEM for 4 different donors. Results suggested that within 
these donors the production of IP-10, MCP-1, MIG and RANTES was induced by 
IFN-γ. Although TGF-β had minimal effect on chemokine production by itself, a 
synergistic effect on chemokine synthesis was observed for IP-10, MIG and 
RANTES when combined with IFN-γ. IL-8 production by PTEC decreased when 
exposed to IFN- γ. However, more samples are required to be tested to confirm 
the findings. 
Next, the effects of IFN-γ and TNF-α on PTEC were studied as previous results 
indicated that TGF-β had minimal effect on the chemokine production of PTEC in 
Figure 4.23 Chemokines produced by PTEC in 2D cultures in response to the 
inflammatory mediators IFN-γ and TGF-β.  
  PTEC produce a range of chemokines known to be chemotactic to monocytes, T cells, 
dendritic cells and neutrophils and these chemokines are up-regulated in response to the 
inflammatory mediators IFN-γ and TGF-β. Data shown are the mean +/- SEM for 4 different 
donors. 
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2D cultures. To examine the effects of proinflammatory cytokines IFN-γ and 
TNF-α on chemokine synthesis by PTEC in 3D and 2D cultures, supernatants 
from the cultures were analysed using a Cytometric Bead Array Human 
Chemokine kit (BD Biosciences). PTEC were cultured in 96 well plates in 
duplicates in presence or absence of IFN-γ and TNF-α, or combination of both. 
For 3D cultures, PTEC were encapsulated within collagen gels and exposed to the 
pro-inflammatory cytokines. The results in Figure 4.24 suggested that in the 
presence of stimulation there was an overall increase in chemokine production 
both in 2D and 3D cultures. IFN-γ and TNF-α by themselves were able to induce 
small amounts of RANTES production both in 2D and 3D but an enhanced 
synthesis of RANTES was observed when these two proinflammatory cytokines 
were combined. Although IP-10 and MIG synthesis were IFN-γ dependent, the 
combination of IFN-γ with TNF-α induced the highest level of these two 
cytokines. IL-8 and MCP-1 were detected in absence of the inflammatory 
mediators but the levels were up-regulated in the presence of TNF-α and more 
Figure 4.24 Chemokines produced by PTEC in 2D and 3D cultures in response to 
different inflammatory cytokines. Data derived from a single donor. 
PTEC were cultured in 96 well plates in duplicates in presence or absence of IFN-γ, TNF-α 
or combinations of both in 2D and 3D. In 3D cultures, PTEC were encapsulated within 
collagen gels and exposed to the pro-inflammatory cytokines. After 36 hours, supernatants 
were harvested from the cultures and analysed using a Cytometric Bead Array kit. 
so in synergy with IFN-γ, especially within 3D cultures. Interestingly, in 3D 
cultures, levels of chemokines produced by PTEC in response to these 
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inflammatory cytokines were consistently lower than those in 2D cultures. This 
preliminary data could possibly reflect the fact that within 3D cultures the cells 
displayed a less stressed functionality, therefore secreting less chemokines in 
response to inflammatory stimuli. However, more data is required to confirm the 
findings.  
PTEC were also analysed alone in both 2D and 3D cultures and found not 
to produce IL-10, IL-12p70 and IL-1β (data not shown). 
 
4.3.2. Immune–cell cytokine profiles in the presence of autologous 
PTEC in 3D collagen model. 
 
Cytokine profiles from CD4
+ 
T cells in the presence of autologous PTEC 
were analysed from supernatants of 2D cultures (Donor 1) using Cytometric Bead 
Array (CBA) Human Th1/Th2 Cytokine Kit II (BD Biosciences). As seen in 
Figure 4.25 a decrease in the amounts of IFN-γ, IL-10 and IL-2 was detected in 
presence of PTEC when T cells were stimulated with anti-CD3/CD28. Optimal 
stimulation was observed through the TCR with anti-CD3/28 inducing the highest 
expression of all cytokines. With PHA stimulation of T cells, a slight increase in 
IFN-γ and IL-10 levels were noted. Also, concurrently sharp increases in IL-4 
levels were observed in the supernatants. These results suggest that the presence 
of PTEC causes a decrease in Th1 type cytokines while enhancing the production 
of Th2 type cytokines (IL-4). TNF-α synthesis decreased in presence of PTEC 
when T cells were stimulated with anti-CD3/28. IL-6 production was not 
monitored because PTEC alone produce higher levels of this cytokine than that 
produced by T cells.  
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Supernatants from 2D cultures of autologous CD4
+
 T cells and PTEC were harvested after 
36 h in culture and analysed using Cytometric Bead Array (CBA) Human Th1/Th2 Cytokine 
Kit II (BD Biosciences). 
 
Following this, another donor was selected and the supernatants from proliferation 
assays in 2D and 3D cultures were tested to detect Th1/Th2 type cytokines 
present. Decreases in IFN-γ, IL-2, TNF, and an increase in IL-4 were detected in 
the 3D model. The pattern of expression of cytokines in the presence of PTEC for 
donor 2 was similar to that of donor 1 both in 2D and 3D for all the cytokines 
except IL-4. In the 3D in vitro culture, the IL-4 mirrored the results from donor 1 
but in the 2D culture IL-4 increased in the presence of PTEC (Figure 4.26). The 
results indicated that in the presence of PTEC there was a skewing of cytokines 
from a Th1 towards a Th2 type profile in 2D and 3D in vitro cultures. 
 
  
 
Figure 4.25 Cytokine profiles of responding CD4+ T cells in presence of activated 
autologous PTEC (Donor 1) in 2D cultures. 
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Supernatants from proliferation assays in 2D and 3D cultures were harvested at 36 h and 
tested to detect the pattern of expression of cytokines using Cytometric Bead Array (CBA) 
Human Th1/Th2 Cytokine Kit II (BD Biosciences). 
 
4.3.3. Summary 
Under diseased conditions, PTEC produce a range of chemokines known to 
be chemotactic to monocytes, T cells, DC and neutrophils and these chemokines 
are up-regulated in response to inflammatory mediators like IFN-γ, TGF-β and 
TNF-α. Once these cells are recruited, they can promote further chemokine 
production from the PTEC. In this thesis, the influence of a more in vivo like 3D 
model on the chemokines and cytokines produced by primary human PTEC in 
presence of pro-inflammatory cytokines was explored. 
Figure 4.26 Cytokines produced in presence of activated autologous PTEC (Donor 2) in 
2D and 3D in vitro cultres. 
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When exposed to IFN-γ or TGF-β and a combination of both, the production 
of IP-10, MCP-1, MIG and RANTES was induced by IFN-γ only. Although TGF-
β did not have much effect on chemokine production by itself, it provided a 
synergistic effect on chemokine synthesis for IP-10, MIG and RANTES when 
combined with IFN-γ.  IL-8 production by PTEC decreased when exposed to IFN- 
γ. 
In the presence of IFN-γ and TNF-α, there was an overall increase in 
chemokine production, both in 2D and 3D cultures. Interestingly, within this 
sample, the levels of chemokines produced by PTEC in 3D cultures in response to 
inflammatory cytokines IFN-γ and TNF-α and both together, were consistently 
lower than 2D cultures perhaps indicating that cells in 3D cultures were less 
stressed. There is also a possibility that the cytokines were bound to the collagen 
matrix and were therefore seemingly lower in abundance in the supernatants 
compared to 2D.The results from the Th1/Th2 cytokine detection kit indicated 
that in presence of PTEC the cytokines produced by responding T cells cause a 
skewing of cytokines from Th1 towards Th2 type profile in 2D and 3D in vitro 
cultures. 
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Chapter 5: Discussion and conclusions 
5.1. Discussion 
This thesis aimed to develop a 3D hydrogel system for the co-culture of 
PTEC and immune cells. To construct a versatile model, various types of 
hydrogels were investigated. Besides establishing a suitable biomaterial that 
would closely resemble the native ECM, the thesis also focused on identifying 
techniques of recovering the cells from the gel matrix to analyse their phenotypic 
and functional characteristics. The immunomodulatory functions of the recovered 
cells were examined and compared with the results from 2D cultures. 
 It is known that in the early stages of kidney disease PTEC play an 
important role in bringing in inflammatory immune cells into the kidney 
interstitium   and are capable of modulating the functions of these immune cells. 
In 2011, Wilkinson et al were able to demonstrate, for the first time, that primary 
human PTEC can modulate autologous T cell and B cell  and DC responses  [3, 
45]. All these studies were carried out in traditional 2D cultures. Research has 
provided evidence that culture conditions affect cell physiology profoundly [125]. 
I hypothesized that a 3D model that better mimic physiological conditions would 
allow the kidney cells and immune cells to exhibit their typical phenotype and 
functionality and this may provide new and interesting insights in regards to how 
these cells interact with each other under in vivo conditions.  
In this study various hydrogels and hydrogel mixtures were used to obtain a 
suitable matrix. The mechanical properties of hydrogels are important for 
adhesion of cells and the expression of various genes. Adhesion, migration or 
differentiation of cells are significantly affected by the interactions of the cells 
with the hydrogels that form the ECM [126]. Alginate gels to some extent are 
similar to ECM in tissues but lack cell adhesion sites and allow no interaction 
between the gel and the cells [89]. For PTEC and T cells, the alginate gels 
allowed a homogenous cell distribution within the hydrogel but cell viability was 
low, limiting its use in creating engineered tissue. To enhance the chances of cell 
binding and spreading within the gel, cell binding motifs were introduced by 
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mixing alginate with either collagen or Matrigel. Though it improved cell viability 
within the gel mixtures compared to alginate itself, considerable numbers of cells 
still died within a week of culture making it unsuitable for the in vitro model.  
Next, photopolymerizable GelMA hydrogel was studied as a potential ECM 
for PTEC and T cell co-culture. The advantages of GelMA are that it is derived 
from inexpensive gelatin and is comprised of modified natural ECM components 
[127]. Gelatin has a wide use in tissue engineering applications and has been 
successfully used to culture different cell types like immortalized HUVEC, NIH 
3T3 fibroblasts [108] and aortic VICs [112]. PTEC readily bound, spread and 
formed interconnections on GelMA, demonstrating the ability of the gel to sustain 
viable PTEC for at least 4 weeks. PTEC formed networks after weeks in culture. 
The short UV exposure of CD4
+
 T cells during the encapsulation process in 
GelMA did not affect viability of T cells although live cell imaging provided 
evidence that T cells were incapable of migrating within GelMA and viability of 
T cells decreased over time. No significant movement of T cells within GelMA 
was observed, perhaps due to the inability of T cells to degrade and remodel the 
matrix. The possibility of T cell death due to continuous exposure to laser light 
was excluded as the microscope (Cell Voyager CV1000) used to take the time 
lapse images is a spinning disk confocal microscope which uses microlens 
enhanced dual Nipkow disk scanning technology and has drastically reduced 
phototoxicity and photobleaching [128]. Only a low level of laser power at the 
specimen is required to fully excite fluorescence. Moreover, the time lapse images 
of the cells within the collagen gel were captured using this same scanning disk 
confocal and the same settings. As shown in the results, the cells migrated through 
the collagen gels with ease. Overall the results suggested that GelMA was not 
well suited for co-culture of PTEC and T cells. 
Collagen fibres are one of the main components of the tissue stroma through 
which lymphocytes migrate in vivo [102]. Collagen gels have been used to study 
migrations of highly motile T cells [106]. The kidney cell line MDCK has also 
been cultured and studied in collagen gels [107]. Thus this thesis also investigated 
the suitability of a collagen type I gel model. Within the collagen gel model 
system, T cell migration and PTEC movement was observed using live-cell phase 
contrast and fluorescence microscopy. Time lapse video microscopy demonstrated 
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dynamic cell – cell interactions suggesting that the collagen gel model system 
provided a suitable ECM for cell co-culture. 
 Single cells tracked within this gel system using Image J software revealed 
that the presence of PTEC slowed down movement of T cells within the gel due to 
the interactions between the cell types. These interactions arrested the movement 
of the T cells. The T cells migrated away from the PTEC after the interaction. 
Such contact ―dwell times‖ are known to be important in a number of immune cell 
modulation/activation events including those that occur at the immune-synapse 
between DC and T cells [129]. 
Earlier study on primary human PTEC in 2D culture showed that IFN-γ had 
the most profound effect on up-regulation of PD-L1 and MHC II (HLA-DR) 
expression [3]. Consistent with that study, PTEC in our 3D in vitro model also 
showed upregulation of PD-L1 and HLA-DR when treated with IFN-γ. Research 
with murine models of kidney diseases have shown that TNF-α plays a role in 
inflammatory renal diseases [130]. There is evidence that the presence of TNF-α 
in inflamed human kidneys is positively associated with the risk of developing 
CKD [131]. Thus, in this study, PTEC were also treated with TNF-α and a 
combination of both IFN-γ and TNF-α. The synergistic effect of the two 
proinflammatory cytokines were observed in 2 donor samples inducing a  
maximum level of PD-L1 and MHC II expression on the PTEC both in 2D and 
3D cultures. However, the data obtained suggested that a higher expression of 
these surface Ags occurred in the 3D model compared to 2D.  
The proliferative responses of CD4
+
 T cells in presence of autologous PTEC 
under inflammatory conditions were studied in 2D and 3D models. In the 
presence of activated autologous PTEC, inhibition of T cell proliferative 
responses was observed in 2D and 3D cultures. However, this down-modulation 
was seen to be greater in 3D cultures than in 2D cultures. One mechanistic 
explanation for this could be that PTEC within 3D cultures displayed a greater 
level of HLA-DR and PD-L1, enabling them to interact with PD-1 and down-
modulate CD4
+
 T cells more effectively. This inhibition was seen when T cells 
were stimulated via their TCR complex using anti-CD3/28 Ab or through 
mitogenic stimulation with PHA. Proliferative responses of T cells were down 
modulated in 5 of 6 donors when stimulated with PHA. Also the proliferative 
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responses varied between donors. These differences are commonly seen in out-
bred human samples. Thus the results indicated that the 3D culture model was a 
more effective system compared to the conventional 2D culture and enabled the 
cells to show appropriate cell physiological responses. Other factors apart from 
increased levels of surface antigen expression may also contribute to the more 
effective 3D culture system. In the 3D system, the PTEC were more widely 
distributed within the hydrogel and T cells were able to successfully move 
through the gel having more contact with the PTEC cells. In contrast, in the 2D 
culture system PTEC formed a monolayer and therefore only a fraction of their 
cell surfaces were exposed to the T cells in culture.  
PTEC express and produce multiple molecules which enable them to 
function as immunomodulatory cells. From previous research it is known that 
activated PTEC act as non-professional APC and down-regulate autologous T cell 
and B cell proliferative responses in 2D cultures and this modulation is partially 
mediated by PD-L1. Here in this thesis, blocking Ab to PD-L1 was used in 3D 
cultures to confirm that this molecule also plays a role in immune modulation 
within this more representative in vivo culture system. The modulation by PTEC 
involves complex mechanisms and multiple molecules. The role of IDO 
expression by primary human PTEC and its effect on autologous T cell 
proliferation was evaluated in 3D cultures. Out of 3 donors, addition of 1-MT 
(inhibitor of IDO) resulted in partial amelioration of inhibition in 2 donors in 3D. 
Within the scope and timeline of this thesis, there were not enough suitable donors 
to repeat this study and further confirm the role of IDO in 3D cultures. 
Aggregation of T cells occurs in the kidney interstitium in many renal 
diseases but the mechanisms by which the T cells cause interstitial injury are not 
well characterized. Research has demonstrated that this interstitial infiltration of 
cells is directed by chemokines released by damaged or activated PTEC [24, 25]. 
In this thesis the effect of proinflammatory cytokines IFN-γ, TNF-α and 
combinations of both on PTEC in 3D cultures were studied. Our previous 
published paper with 2D cultures demonstrated that the cytokine profile shifted 
away from the Th1 type profile towards a Th2 type profile [3]. This study 
confirmed that within 3D in vitro cultures, higher levels of IL-4 and lower levels 
of IFN-γ, TNF-α, IL-2 and IL-10 were also produced in the presence of activated 
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autologous PTEC, emphasizing that these cells induce a shift away from an 
inflammatory Th1 responder T cell profile towards a Th2 type profile in the 3D in 
vitro model. Highest levels of cytokines were expressed when CD4
+ 
T cell 
stimulation occurred through their TCR complex using anti-CD3/28. 
 
5.2. Conclusions and Future directions 
In conclusion, it was evident from the results that a 3D in vitro model of 
collagen was well suited to co-culture PTEC and T cells. As using this 3D 
collagen matrix model, we could easily observe migration of T cells and their 
interactions with PTEC under in vivo-like inflammatory conditions using time 
lapse video microscopy. In addition, PTEC were able to down-modulate T cell 
immune responses more effectively within this collagen based model as opposed 
to their 2D controls. Collagen gels could be dissolved easily to recover the cells 
and study their expression of cell surface antigens. Consistent with 2D cultures, 
activated PTEC were capable of up-regulating PD-L1 and MHC class II 
molecules within this 3D in vitro model. Also CD4
+ 
T cells up-regulated their 
activation markers within the collagen gels. The cytokine profiles of responding 
CD4
+ 
T cells in the presence of activated autologous PTEC in the 3D in vitro 
model were consistent with 2D results and suggested that the cytokine profile 
resembled more the Th2 type. 
Overall the results suggested that the 3D in vitro model created an 
environment where both cell types expressed a more in vivo like phenotype. 
PTEC were capable of showing a greater down-modulation of proliferative 
responses of the CD4
+
 T cells within the 3D collagen model as compared to the 
2D culture system. 
An interesting observation in the time lapse videos of PTEC (refer video 3) 
cultured in collagen revealed small vesicle-like structures being released by these 
cells. There could be the possibility that such vesicles contain a range of factors or 
molecules that could be involved in our observed immune modulation. However it 
should also be noted that apoptotic cells undergo blebbing which may partially 
account for what we have observed in the videos. Further characterization is 
needed to draw any conclusions. 
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 Further investigation of the mechanisms by which PTEC modulate the 
autologous immune responses using the 3D collagen model may reveal new 
interesting insights and enhance our understanding of the role of PTEC during 
inflammatory kidney disease. This may enable us to offer targets for diagnostic 
and therapeutic intervention at earlier stages of renal disease.
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